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ABSTRACT 
Leprosy, caused by the bacteria Mycobacterium leprae and Mycobacterium 
lepromatosis, is a chronic, infectious disease that eventually causes disfiguring skin 
lesions, nerve damage, and muscle weakness. Even though leprosy has been nearly 
eliminated in many parts of the world today, it remains endemic in India, Myanmar, 
Nepal, Brazil, and a few African countries. Unfortunately, this infectious disease is not 
limited to just modern populations. In the past, leprosy spread globally and was a 
pervasive, degenerating disease. The literature traces leprosy back to 1550 BCE although 
there is possible skeletal evidence of leprosy in Rajasthan, India from 2000 BCE, 
suggesting it originated there and spread on a larger scale, but leprosy’s dissemination 
remains uncertain.  
Presently, numerous scientific articles exist on the paleopathology of leprosy, but 
no meta-analysis of leprosy has ever been done. In this paper, a meta-analysis was 
conducted on 1,645 paleopathological cases of leprosy found in 102 sites ranging from 
3125 BCE to 1905 CE. This meta-analysis statistically tested the prevalence of leprosy 
based on the paleopathological literature to chart the pathogen’s occurrence. First, a 
comprehensive search was conducted on previously published peer-reviewed literature to 
identify archaeological sites where leprosy was reported. These were geographically and 
temporally grouped together to trace the disease’s effect in the varying populations over 
time. Second, the null hypotheses that the frequency and distribution of bone lesions due 
to leprosy did not change through time were tested. Results suggest that the frequency 
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and distribution of bone lesions did change over time, increasing in frequency in the Iron 
Ages and the Middle Ages, contrary to the null hypotheses. 
Additionally, the average age at death of a leprosy sufferer rose almost 12 years 
from the Bronze Age to the Iron Age (26.6 years versus 38.3 years). Age at death 
remained relatively constant through the Middle Ages. There were more male skeletons 
than female skeletons (N = 312 versus N = 221) although females died at a younger age 
than males in all time periods analyzed except the Bronze Age. 
This project suggests that Mycobacterium leprae originated in South Asia, slowly 
reaching Europe where it spread quickly and prospered for over 400 years, dramatically 
declined worldwide, and was eventually introduced to the New World likely through 
colonialism and the slave trade.  Due to a rise in co-infection with other pathogens and 
improved social conditions, Europeans likely developed a natural resistance to leprosy. 
Leprosy’s current global situation is also discussed, with 1.15 million infected individuals 
as of 2013 (World Health Organization, 2016). This is the first meta-analysis examining 
leprosy’s global imprint in the archaeological record and provides evidence for how bone 
lesion frequency and distribution changed across time and space. 
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CHAPTER ONE: INTRODUCTION 
Brief Introduction 
Paleopathology is defined as the study of pathological conditions found in human 
remains or contexts. Pathological studies of skeletal data have demonstrated that health 
and diet were at an all-time low in the medieval period (Porter, 1999:25). Today, 
meanwhile, medicines and antibiotics serve to cure some of the worst infectious diseases. 
Modern medicine and medical research work toward furthering disease and injury 
prevention, cure, and individual wellbeing. 
Leprosy 
Leprosy, also known as Hansen’s disease, is a chronic, curable infectious disease 
mainly causing disfiguring skin lesions, nerve damage, and muscle weakness. It is 
transmitted by nasal or oral droplets although only about 10% exposed to the disease 
actually get it (Covey, 2001:315). Although it is curable, blindness, paralysis, and severe 
disfigurement can manifest if unchecked and untreated. 
More than 1.15 million people suffer from leprosy worldwide, with 215,557 new 
cases reported in 2013, mainly in South Asia, Africa, and South America (World Health 
Organization, 2016). However, except for pockets in Angola, Brazil, the Central African 
Republic, India, Madagascar, Nepal, Myanmar, and Tanzania, the disease is classified as 
eliminated, defined as below one case per 10,000 population (ibid).  
There are two species of bacteria that cause leprosy: Mycobacterium leprae and 
Mycobacterium lepramatosis. Mycobacterium lepramatosis was discovered in 2008 in 
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Mexican populations and is a lesser agent of leprosy than Mycobacterium leprae (Han et 
al., 2008). M. leprae is an aerobic bacillus bacteria, enclosed in a characteristic waxy 
coating, resembling Mycobacterium tuberculosis in its size and shape.  
Leprosy can be diagnosed as paucibacillary, a more moderate form of leprosy 
containing just a few lesions, or multibacillary, which is more severe and indicates more 
than five lesions present. Based on the severity of the symptoms, WHO classifies the 
disease into six classes through a Ridley-Jopling system, beginning with early 
indeterminant (I) leprosy and continuing with polar tuberculoid (TT) leprosy, borderline 
tuberculoid (BT) leprosy, mid-borderline (BB) leprosy, borderline lepromatous (BL) 
leprosy, and polar lepromatous (LL) leprosy (Pardillo et al., 2007:1096). Lepromatous 
leprosy (BL and LL) is the more contagious form of leprosy since the body is unable to 
form a resistance. Usually, BL or LL sufferers develop nodules all over body and face. 
Tuberculoid leprosy (TT and BT) is a less contagious form of leprosy. The skin grows 
dry, discolored, and loses feeling and most often affects the fingers and toes and is a 
common cause of blindness. 
Furthermore, this chronic infectious disease is difficult to acquire, but a weakened 
immune system increases risk of disease, and signs of it may not show for 6 months up to 
a few decades after initial contact. M. leprae is extremely slow growing after contact and 
needs to be in an intracellular environment within its host (Donoghue et al., 2015:5141). 
Even after a diagnosis of leprosy, it can be years until lesions appear on the body. In the 
first stages of the disease, lesions are barely noticeable and do not itch and therefore, are 
often ignored by the individual. As the disease progresses, nerve damage and other 
3 
 
 
 
complications arise, including the characteristic deformities on the face and extremities 
(World Health Organization, 2016).   
Historical Background 
Today, the diagnosis and treatment of leprosy is unproblematic and most 
countries have achieved elimination at a national level (Bennett et al., 2008:198-9). In the 
past, before a cure was available, there was widespread fear of contracting leprosy which 
lead to the social exclusion of individuals who displayed symptoms of the disease. It is 
believed that it was first recorded on an ancient Egyptian papyrus document written 
around 1550 BCE, and around 600 BCE, Indian writings describe a skin disease that 
appears to have been leprosy (Hulse, 1972; Dharmendra, 1947). Numerous hymns of the 
four thousand year old Sanskrit text, Atharva Veda, discuss health problems that some 
scholars believe to be leprosy. The Sushruta Samhita (600 BCE), an ancient Sanskrit text 
describing primeval surgery and Indian medicine, is considered the oldest Indian writing 
describing the physical malformations of leprosy (Bloomfield, 2004). 
The word tsara’ath in the Leviticus 13:9-46 (the Torah or the Old Testament), 
translated as ‘leprosy,’ used to be considered the oldest reference to the disease in history. 
Tsara’ath in Hebrew was later translated into Greek as lepra, or “scaly.” However, it is 
now thought that ‘leprosy’ was used to categorize a broad variety of skin diseases 
(Møller-Christensen, 1967; Aufderheide and Rodriguez-Martin, 1998; Lechat, 2002), 
designating a state of moral uncleanness and ritual impurity for all sufferers (Grmek, 
1991; Roberts and Manchester, 1995; Zias, 2002; Mariotti et al., 2005:311). The New 
Testament also contains references to lepers, but describes malformations that are 
unlikely characteristic of clinical leprosy.   
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For many years, leprosy was feared and misunderstood since many people 
thought of it as a hereditary disease, a curse, or even a punishment from God or some 
higher deity (Bennett et al., 2008:199). European sufferers were outcasts from society 
and had to ring bells to warn others of their approach. Victims were also pressured to not 
procreate, believing that the disease was hereditary. The public perception that people 
with the disease were unclean was derived from biblical scriptures, fearing that leprosy 
was a “moral disease” (Covey, 2001:316). Leviticus 13:44-46 states, “Now whosoever 
shall be defiled with the leprosy [tsara’ath], and is separated by the judgement of the 
priest, shall have his clothes hang lose, his head bare, his mouth covered with a cloth, and 
he shall cry out that he is defiled and unclean. All the time that he is infected and unclean, 
he shall dwell alone without the camp” (ibid). 
This social stigma continued for most of its history, contributing to the barrier in 
self-reporting and medical treatment. It is nearly impossible to quantify the patients of 
centuries past based on the historical literature, so scholars have turned to other sources 
to help portray leprosy’s history, especially demographic information such as church 
records and bioarchaeology. Leprosariums, usually sustained by the church, maintained 
some of the best medical records during the medieval ages. 
Leprosy became a serious health problem in the medieval era and leprosy 
asylums, or “leprosariums,” also called “lazar houses,” typically run by monastic orders, 
were established in mass quantities in the United Kingdom, Denmark, Portugal, France, 
Germany, Sweden, Czech Republic, Italy, and Hungary (Robbins et al., 2009:5669; 
Antunes-Ferreira et al, 2013; Boldsen, 2001; Magilton et al., 2008). While episcopal 
support and private endowments financed most medieval European leprosariums, 
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leprosariums in Western Europe “had other unique sources of income” (Miller and 
Nesbit, 2014:130). In most cases, these leprosariums charged an admission fee by its 
patrons and their families or ran a business on the side to earn revenue. The business set-
up of these leprosariums excluded some needy candidates who could not afford its 
services. Outside of Europe, leprosariums also became widespread in India during the 
medieval period (Granoff 1998:220). After the medieval era, leprosariums grew popular 
outside of Europe and were built in countries such as Japan, Syria, Israel, South America, 
and a few in the United States (Miller and Nesbitt 2014:73). 
There is debate in the paleopathological literature on the oldest known skeleton 
with leprosy. Recently, a skeleton dating to 2000 BCE in Rajasthan, India was excavated 
bearing signs of leprosy (Robbins et al., 2009). Also in 2009, Köhler and colleagues, 
published a site report from Abony-Turjányos dűlő, Hungary on 2 probable leprous 
skeletons from 3215 BCE, but as of 2015, this article has not been translated into English 
(Köhler et al., 2009). This case from Hungary has not been cited in any subsequent 
paleopathological publications on leprosy. 
 In the 2007, Roberts provided an account of two burial cists dating to 2300 c. – 
2000 c. BCE in Dryburn Bridge, East Lothian, Scotland. One of these cists (burial 11) 
contained a leprous 6-8 year old child pathological by identified with rhinomaxillary 
changes (2007:18-25). In contrast to Köhler et al., this report has been cited in the 
subsequent paleopathological literature yet articles published in 2015 still refer to the 
burial in Balathal, Rajasthan, India as the “oldest” documented case of leprosy 
(Kjellström, 2012; Taylor et al., 2013:17). In light of this confusion, one of the main 
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goals of this systematic review of the literature is to provide evidence to resolve this 
debate. 
Since leprosy does not act as an immediate killer, it has remained more stable 
than most other infectious diseases (Boldsen, 2009:409; Monot et al., 2005). Modern 
leprosy is a disease that the sufferers die with, not from (Boldsen, 2005:165). Leprosy is 
frequently seen in co-infection with other diseases, observed in burials dating to the 
Yersinia pestis and Mycobacterium tuberculosis epidemics a few hundred years ago 
(Pálfi and Molnár, 2011; Donoghue et al., 2005).  
Additionally, according to Monot et al. (2005), leprosy was much more of an 
epidemic in the past than it is today. The skeletal pathology and epidemiology of another 
well-known Mycobacterium, Mycobacterium tuberculosis, also an epidemic in the past, 
remains a big threat to global health. Both M. tuberculosis and M. leprae grow 
remarkably slow for bacteria, taking tuberculosis and leprosy, respectively, months or 
sometimes years to develop. Around one-third of the world’s population are infected with 
tuberculosis and about 2 million people die each year from the disease while mortalities 
from leprosy number around 4,000 annually (Stone et al., 2009).  
 Both leprosy and tuberculosis were prevalent, or a common threat, in Europe 
throughout the first thousand years after the fall of the Roman Empire, but thereafter 
leprosy suddenly declined. It is not known why this occurred, but Donoghue et al. 
(2005:389), Roberts & Manchester (1995), and Lietman et al. (1993; 1997) suggest that 
cross-immunity protected tuberculosis patients from leprosy. They coexisted in antiquity, 
but tuberculosis sufferers had increased mortality and therefore, there was a historical 
decline in leprosy to where it is almost non-existent today.  
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Leprosy, unlike TB, is an Old World disease. Most historians agree that the 
disease originated in Asia as early as 2000 BCE. By 400 CE, the first leprosariums were 
built in Cappadocia and in Europe (Aufderheide and Rodriguez-Martin, 1998). Skeletal 
evidence of the disease is scarce until 400 CE, when the disease emerges in the UK 
(although not for the first time), likely spreading by the Roman army (Donoghue et al., 
2015; Monot et al., 2005). The Crusades resulted in high leprosy infection rates 
throughout most of medieval Europe, with hundreds of leprosariums emerging in 
Denmark and the UK. All pre-16th century leprous skeletal remains are from Old World 
contexts (Table 1; Stone et al., 2009:71). Leprosy only reached the New World (North 
and South America) in the 16th and 17th centuries, likely by European explorers and 
migration. During the 19th century CE, Europeans spread the disease into Oceania 
(Aufderheide and Rodriguez-Martin, 1998; Smith, 2010:12). However, the earliest 
bioarchaeological cases of leprosy in Western Micronesia date from the 7th to the 15th 
centuries, making them the oldest known leprous individuals in Oceania (Trembly, 1995). 
In the past millennium or two, however, leprosy spread like the common cold and 
was a chronic, widespread disease. After possibly originating in Asia, the disease was 
ubiquitous in Europe in the medieval period, but many people were likely misdiagnosed. 
Before standard terminology for different pathologies were invented, leprosy served as 
the “de facto” term for anyone suffering from a skin infection that left lesions on the 
bone. Therefore, early reports of leprosy could have been discussing another disease 
entirely, affecting the accuracy of the numbers. This problem persisted until Gerhard 
Armauer Hansen described the bacteria causing the disease in 1873 (Monot et al., 2005; 
Taylor et al., 2006). Despite this supposed “misdiagnosis” with syphilis, yaws, bejel, 
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pinta, tuberculosis, and numerous other skin conditions, leprosy was at full force for two 
thousand years. To keep up with the “demand,” the United Kingdom instituted hundreds 
leprosariums within 12th to 16th centuries alone (Roberts, 2002a). 
Leprosy has since nearly died out in Europe and most of the Western World; with 
rare cases appearing in the skeletal record within the past 450 years after a sudden decline 
in cases in the 16th century. This is remarkable considering the infection did not arrive in 
the New World until the 18th century likely through colonization and the slave trade 
(Stone et al., 2009). 
Multiple hypotheses to explain leprosy’s drastic decline beginning in 1400 CE 
have been proposed. One explanation that has been suggested is that late medieval people 
eventually developed increased resistance to the disease after the widespread death of 
those most vulnerable to the disease (Mendum et al., 2014; Monot et al., 2009). 
Additionally, it is possible that the power of leprosy faltered due to the heavy competition 
with other diseases such as Mycobacterium tuberculosis and Yersinia pestis, or the 
“Black Death” (Monot et al., 2009:1287). The Black Death spread throughout Europe in 
1346-1353 CE, killing 30%-60% of Europe’s population and 25% of the world 
population. Lastly, the improved living conditions, better sanitation, and strict quarantine 
efforts/superior medicine practices, especially after the Black Death, have been offered as 
reasons for leprosy’s unexpected decline (Bennett et al., 2008:199). 
Currently, leprosy is a curable disease with the use of multi-drug treatment 
(MDT) which may last from 6 to 24 months. Treatment should be provided in the early 
stages of the disease in order to prevent permanent disability. Before the World Health 
Organization introduced MDT in 1981, the possibility of curing leprosy through medical 
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treatment was not possible as the disease itself was little understood, particularly its 
transmission and how to care for someone who had it (World Health Organization, 2016). 
Not much is known about medical treatments for leprosy before the medieval ages but for 
the most part, early attempts at medicine were basic, naturalistic, and medicated by herbal 
remedies.  
Medieval physicians, especially during the Renaissance era, used a wide variety 
of treatments to try to care and cure the disease. Some of these methods included rubbing 
hydnocarpus oil on the body, eating white lilies or the soil of ant-hills, spilling blood, 
drinking mercury, and amateur dissection and amputation (Covey, 2001:319; Rasmussen 
et al., 2008). Spiritual health was also closely linked to physical health as prayer and 
religion served as the most prescribed medicine. To answer the spiritual aspects of 
leprosy, many churches and monasteries ran and maintained leprosariums and promoted 
pilgrimages (Covey, 2001:319).  
Although tremendous advances have occurred in the past three decades in the 
understanding and treatment of the disease, much remains unknown about the disease’s 
transmission and pathogenesis (Bennett et al., 2008:198). It is a considerable debate as to 
whether the bacteria Mycobacterium leprae originated in ancient Europe, Eastern Africa, 
India, or the Near East centuries ago. One study, using comparative genomics from 21 
countries, traced the strain of M. leprae by sequencing rare single-nucleotide 
polymorphisms of leprosy back to Eastern Africa or the Near East (SNP-type 1) and 
showed that leprosy was likely then spread through human migration and colonialism 
(Monot et al., 2005). The disease then grew rampant in Western Africa and Europe until 
about 450 years ago. This 2005 study is further explored in Chapter 5. 
10 
 
 
 
The most accepted hypothesis, similar to that in Monot (2005) is that leprosy 
originated in Southern Asia, spread through the Old World, and was introduced to the 
New World by Spaniards, through the African slave trade, and colonialism. The 
possibility of an African origin has been thoughtfully considered as well but that is likely 
no longer an option after the discovery of skeletal evidence for leprosy in Rajasthan, 
India, the oldest known case of leprosy at 2000 BCE (Grmek, 1991; Robbins et al., 2009)  
Leprosy Today 
With the introduction of multidrug therapy (MDT) by the World Health 
Organization in 1981, leprosy is curable and treatment in the early stages prevents 
permanent disability. Since 1995, the World Health Organization has supplied the triple 
antibiotic course free of charge to all leprosy patients. MDT regimens combine rifampin, 
clofazamine, and dapsone in the treatment of leprosy (Bennett et al., 2008:201; Setia et 
al., 2006:162). Despite WHO providing MDT free of charge, a 2015 study found that 
leprosy affects poor and marginalized communities in developing countries, pushing 
affected households deeper into poverty (Chandler et al., 2015). Further out of pocket 
expenses and lost productivity (ability to earn an income) keeps disabled individuals at a 
constant disadvantage. 
Even though leprosy is nearly eliminated, it remains endemic in parts of the 
world, with India accounting for about 60% of all registered cases (as of 2012; WER 
2012 Index). In regions considered European or ‘New World,’ it remains endemic only in 
Brazil (1-2 cases per 10,000 people). Although more rare, there have been cases reported 
issue in Venezuela, Paraguay, and the Dominican Republic (based on rate detected per 
10,000 in 2011; Figure 1) (ibid).  
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Figure 1. Frequency of leprosy in 2011 worldwide per 10,000 population 
(WHO, 2012) 
Purpose 
The Value of a Meta-Analysis 
A meta-analysis fills the gaps in knowledge using a large set of archaeological 
findings. Thus, a meta-analysis of the prevalence and impact of leprosy throughout 
history is useful to trace the pathways of the disease in addition to providing insight into 
why M. leprae died out in most of the Western hemisphere over 450 years ago, yet still 
remains a problem in other countries. A meta-analysis takes effect sizes from individual 
studies that investigate the same question, quantify the observed effect in a standard way, 
and then combines these effects to get a more precise idea of the true effect in the 
population (Field, 2013:879).  
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The purpose of this research project is to expand our understanding of the impact 
of leprosy on past populations through a meta-analysis on the paleopathological literature 
by compiling and categorizing published and unpublished independent archaeological 
data on leprosy. A meta-analysis serves to provide a more comprehensive overview of 
this ancient chronic disease and its effect through time. This project uses statistical 
techniques to identify patterns among the study results. 
While Roberts (forthcoming) is publishing a compendium of leprosy through 
history and numerous scientific articles exist on the archaeology of leprosy, no meta-
analysis of leprosy has ever been done. This research is the first meta-analysis examining 
leprosy in the archaeological record, although there are meta-analyses on other 
pathologies (tuberculosis, Holloway et al., 2011; malaria, Setzer, 2014; Smith-Guzmàn, 
2015, os acromiale, Yammine, 2014; syphilis, Boekhout, 2009). Bratschi et al. (2015) 
recently published a systematic literature review in Leprosy Review on the current 
knowledge of the transmission of Mycobacterium leprae, concluding that there are no 
studies that indisputably demonstrate the mechanisms behind the transmission of leprosy.  
A paleopathological-based meta-analysis has the potential for enormous broader 
impacts in bioarchaeology and paleopathology. Despite considerable excellent work done 
studying leprosy, much about the infectious disease remains unknown, including its 
origin, initial transmission routes, and the timing of the spread of the disease (Robbins et 
al., 2009). This study is organized two-fold: First, I grouped archaeological findings on 
leprosy geographically and traced the disease’s effect, or frequency, in the varying 
populations. Second, I tested two null hypotheses; (1) the frequency of bone lesions due 
to leprosy did not change through time and (2) the distribution of lesions throughout the 
13 
 
 
 
skeleton did not change over time. These null hypotheses are based on two research 
questions asking how the frequency of leprosy changes through time and how the 
distribution of lesions throughout the skeleton changes through time. It is assumed that 
the distribution of lesions throughout the skeleton correspond to the type of leprosy the 
individual had: lepromatous leprosy or tuberculoid. If the null hypotheses are confirmed, 
then leprosy has remained constant throughout time and the type of leprosy has not 
changed. If the null hypotheses are falsified, however, then the frequency and type of 
leprosy have changed over time. With higher frequencies of leprosy, it is assumed that 
there was increased migration, increased population density, and overall decreased 
sanitation. 
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CHAPTER TWO: LITERATURE REVIEW 
Review of Past Studies: Geographical Division 
Leprosy in Northern Europe 
Due to the pioneering work of Møller-Christensen and Boldsen, bioarchaeological 
information on leprosy in Denmark is exhaustive (Møller-Christensen, 1978, 1967, 1965, 
1952; Boldsen, 2013, 2009, 2008, 2006, 2005a, 2005b, 2001). Sixty-nine percent of this 
project’s skeletal sample derives from Denmark. Regardless of large numbers of 
Mycobacterium leprae in its Scandinavian neighbors, there is no physical evidence of 
leprosy in Finland’s skeletal record, although Vuorinen reported a leprosy hospital in 
Finland in 1355 CE (Vuorinen, 2002). Explanations for the absence range from 
environmental factors to TB co-infections leading to a nonsurvival of identifying leprosy 
lesions.  
Leprosy is rare in the UK until the Roman period (4th century CE) and then 
increases in the early and late Medieval periods; only one case is seen in the post-
Medieval period (Roberts et al., 2007, Roberts, 2002a; Walker, 2009). Eleven percent of 
the entire sample used in this data came from the UK. The data also includes Northern 
European skeletons from Sweden (Arcini, 1999; Nuorala et al., 2004; Linderholm and 
Kjellström, 2011) and Ireland (Murphy and Manchester, 2002). Even though leprosy 
disappeared from Middle Europe almost completely by the 18th century, the disease 
remained in the Baltic and Scandinavian countries (Nerlich and Zink, 2008:109). 
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Norway, Iceland, and the UK still had issues with leprosy after the medieval ages ended 
but by the 1920s, new cases rarely occurred. 
Leprosy in Central and Western Europe 
Much like Denmark and the UK, Hungary has also received a significant amount 
of attention in the paleopathological literature due to leprosy’s large presence before and 
during the medieval period (Csóri et al., 2009; Pálfi, 1991; Pálfi et al., 2002; Pálfi and 
Molnár, 2009; Marcsik and Molnár, 2007, 2002; Molnár et al., 2015; Mészáros et al., 
2005; Donoghue et al., 2005; Donoghue et al., 2015; Köhler et al., 2009). After the 
medieval era, leprosy became rare in Hungary. In the Czech Republic, the discovery of 
two Czech individuals by Likovský et al. (2006) suggest that leprosy existed there prior 
to the Crusades (2006:1276). Historical evidence cites confirmation of leprosy hospitals 
in Czech Republic back to the later medieval period (Strouhal et al., 2002). 
Much like the rest of Central and Western Europe, Portugal had a surge in leprosy 
cases in the 14th to 16th centuries (Antunes-Ferreira et al., 2013; Ferreiera et al., 2013). 
This rise in leprosy is typically associated with increased population density, migration, 
and decreased sanitation, leading to a virulent environment for the disease to spread in. 
This project includes the data from two leprosariums in Portugal, the Lagos leprosarium 
and the Beja leprosarium. Other Central and Western European countries, such as Austria 
and Germany, had cases of leprosy in the Iron Age and the medieval era (Gausterer et al., 
2015; Boldsen, 2008; Boldsen et al., 2013; Szilvássy, 1980). 
Leprosy in the Mediterranean 
Leprosy in Italy has a long history, thanks to human migration and trading. The 
earliest case of leprosy in Italy, in Casalecchio di Reno, Bologna, dates to the 4th and 3rd 
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centuries BCE (Mariotti et al., 2005). Paleopathological literature references multiple 
cases of leprosy in the Iron Age, but most cases date to the early/middle medieval period 
(Rubini and Zias, 2009; Rubini et al., 2012; Rubini et al., 2014; Belcastro et al., 2005).  
While only a few skeletons used in this data originate from France (Blondiaux et 
al., 2015; Blondiaux et al., 2002), social stigma against leprosy in France has a long place 
in the historical literature. In 1321, King Philip V was informed of a plot to poison the 
wells and springs of Aquitaine and subsequently, issued a decree that led to riots across 
France against lepers. French towns like Pamiers, Toulouse and Rouen, Normandy 
erected leprosariums to contain these “vagrants” and soon saw large crowds of people 
burn leprosy sufferers alive without trail (Miller and Nesbitt, 2014:96-7). King Charles V 
of France followed suit and complained that they “were overtaking Paris” (Covey, 
2001:319).  
Besides the historical literature and religious texts, Israel and Egypt have 
documented bioarchaeological evidence proving that leprosy existed in those two 
countries for a long time, providing some of the oldest samples in this project (Matheson 
et al., 2009; Molto, 2002; Dzierzykray-Rogalski, 1980). Rafi et al. (1994), Spigelman et 
al. (2002), and Møller-Christensen et al. (1966) have also recorded skeletal evidence for 
leprosy in Israel and Egypt. Turkey (Rubini et al., 2012), Cyprus (Baker and Bolhofner, 
2014), Croatia (Watson and Lockwood, 2009), and Spain (Montiel et al., 2003) also have 
skeletal evidence for leprosy.  
Leprosy in Asia, Oceania, and the New World 
Most of the oldest leprosy cases are found in Asia and the Middle East. The oldest 
accepted osteological evidence for leprosy is found in India. Robbins et al. (2009) 
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published findings of the earliest skeletal evidence for leprosy, traced to a Late Indus Age 
burial in India from 2000 BCE. Additionally, two individuals with leprous lesions from 
Noen U-Loke, Thailand have been dated to 300-200 BCE and 1st to 2nd centuries CE and 
six from Armenia date to the 2nd to 1st centuries BCE (Tayles and Buckley, 2004; 
Khudaverdyan, 2010). Burial context tells us that leprosy was present, if not prevalent, in 
Asia centuries before it was ubiquitous in Europe. 
Leprosy traveled throughout Asia during the Iron Age. A single leprous individual 
from the Ustyurt Plateau in Uzbekistan dates to the 1st to 4th centuries CE and two have 
been found in Georgia dating to the 6th to 10th centuries CE (Blau and Yagodin, 2005; 
Neil, 2003). Two dating to the Han Dynasty (206 BCE to 200 CE) were excavated in 
Shanxi Province, China (Zhang, 1994). A few centuries later, leprosy was recorded in 
Syria (Miller and Nesbit, 2014) and Japan. Historical literature documents leprosy in 
Japan as early as the medieval period; however, the earliest skeletal evidence dates to the 
18th century CE (Suzuki et al., 2010, 2014).  
Leprosy travels to the Pacific through China and Japan during the late Iron Age/ 
early medieval era and grows virulent after the medieval era ends. In Guam and Saipan, 
western Micronesia, six cases of leprosy were found across three Oceanic sites ranging in 
date from 7th to 11th centuries CE (Trembly, 1995). People born in Oceania had one of the 
highest prevalence of leprosy during the 18th to early 20th centuries outside of India and it 
remains an issue in Federated States of Micronesia, the Marshall Islands, Kiribati, Papua 
New Guinea, and the Philippines today (WPRO, 2016). 
Meanwhile, skeletal evidence for leprosy in Chile and the Netherlands Antilles 
date to the Early Modern Era (post-1536 CE) (Gilmore, 2008; Polet, 2011). Since leprosy 
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did not exist in the Americas until post-Columbus exploration and conquest, there are no 
leprous skeletal remains dating to the Bronze Age, the Iron Age, or the medieval era.  
Leprosy was never endemic in the United States (none of the skeletal samples 
originate from there and leprosy was not documented in Hawaii until 1823 CE), but cases 
of leprosy in Louisiana were first reported in the 18th century, likely resulting from 
migration and the slave trade (Nerlich and Zink, 2008:109). It was endemic in Louisiana 
between 1835 and 1970 and relatively high rates were found in Texas, although nowhere 
near the rate found in medieval Europe. The first leprosarium in the US existed in 
Carville, Louisiana from 1894-1999 and Baton Rouge’s National Hansen’s Disease 
Clinical Center remains a leader in research into multidrug therapy (Boeckl, 2011:22). 
Bioarchaeological Considerations 
All these things considered, there are other factors that affect the placement of 
leprous remains in the archaeological record. A frequent problem in correctly assessing 
health status in past populations is the conflicting interpretations pathological lesions in 
archaeological skeletal populations leave. The “Osteological Paradox,” as Woods et al. 
(1994) deems this phenomena, is the problem that arises in bioarchaeological 
interpretations since the frequency of lesions in a skeletal sample(s) will always be higher 
than in the living population due to heterogeneity of risk and selective mortality (635). 
Specifically, those individuals that are most likely to enter the sample (or at the most risk 
of dying at any given age from any given factor) with osteological lesions were those old 
enough to have lesions form on their skeleton. Those suffering from a pathogen that died 
too young or before they endured the disease for too long, lack visible osteological 
lesions, appearing as if they never suffered from the disease at all. Donoghue et al. (2005) 
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lamented that, since only about 5% of pre-antibiotic lepromatous leprosy cases involve 
bone changes, the number of paleopathology-reported leprosy cases will always be 
under-estimate (251). Thus, using skeletal remains to determine leprosy rates may 
underestimate the actual numbers of people who experienced the disease. In spite of this 
setback, the number of leprosy cases reported from paleopathological literature compared 
against the number of the total population examined for lesions provides valuable clues 
into the rates of leprosy over space and time. Nevertheless, the Osteological Paradox is 
crucial to remember in any bioarchaeological assessment of a past population. 
Useful biocultural information is further restricted by present political, 
socioeconomic, cultural, and preservation issues. Osteological attempts measuring 
leprosy’s distribution are hindered by these factors, which ultimately compromises 
accurate estimations of the disease’s proportion and impact throughout time. While 
bioarchaeological interpretations suggesting an increase in leprosy in medieval Europe is 
supported by the historical literature, the distribution of leprosy in the archaeological 
record in many under-represented countries are affected by the aforementioned factors.  
Political and socioeconomic instability affect the progression of archaeological 
work in a country. The impact leprosy's had in many Middle Eastern, Asian, and African 
countries is likely incorrectly assessed since it is difficult for archaeologists to acquire 
permits to work in those places. Archaeology has also been impacted by government 
propaganda, protests, wars, disinterest, and lack of funding. Bioarchaeology in Denmark 
and the UK are very well-funded and supported by academics and locals, leading to a rise 
in publications in those countries (Gamble, 2014).  
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Lastly, issues in preservation and diagnosis also impact leprosy’s representation. 
There are a few problems found in many osteological investigations (i.e., poor bone 
preservation, inter-observer error, variations in recording lesions, and difficulties in 
aging) (Judd and Roberts, 1998:44). Leprosy lesions look similar to those caused by 
syphilis and tuberculosis, which have caused misidentifications and overestimations in 
the past (Suzuki et al., 2010; Holst, 2012). Additionally, diagnosing leprosy by scoring 
lesions using a technique that is over 60 years old is not as secure of a diagnosis method 
as DNA analysis (Møller-Christensen, 1952). Studies that exclude DNA analysis might 
suffer from inaccuracy in their estimations of leprosy’s prevalence.  
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CHAPTER THREE: METHODS AND MATERIALS 
Data Collection 
Literature Search 
A literature search was conducted using a number of online databases including 
Academic Search Premier, Google Books, Google Scholar, JSTOR, ProQuest, PubMed, 
ScienceDirect, SpingerLink, Web of Science, and Wiley Online Library. Peer-reviewed 
articles were also searched for within Leprosy Review, the International Journal of 
Leprosy and Other Mycobacterial Diseases, AJPA, the International Journal of 
Osteoarchaeology, the International Journal of Paleopathology, and The Past and 
Present of Leprosy, edited by Roberts et al. (2002).  
Additionally, online publication sharing websites ResearchGate and Academia 
were utilized to aid in the search. They were primarily used to find full-text documents. 
Through these websites and through email, numerous authors were generous enough to 
send copies of their work and answer any further questions. A bioarchaeologist 
specializing in tuberculous and leprosy was contacted to inquire about the existence of 
any unpublished meta-analyses and thirteen articles were received by the author 
themselves.  
Criteria for Consideration and Exclusion 
The search terms included: “paleopathology,” “leprosy,” “history,” “Hansen’s 
[disease],” “skeletal,”  “remains,” “lesions,” “Mycobacterium leprae,” “infectious 
disease,” “meta-analysis,” and “archaeological remains.” Articles were searched using 
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four different combinations of terms in order to maximize the scope of references used 
(Table 3). The four search combinations were: (1) “leprosy” and “paleopathology”; (2) 
“leprosy” and “history” or “leprosy” and “skeletal” and “remains”; (3) “leprosy” and 
“lesions” or “leprosy” and “paleopathology” and “lesions”; (4) “leprosy” and “meta 
analysis” or “leprosy” and “archaeology.” The results of the search terms are explained 
and discussed further in Chapter 5. 
This review removed duplicate references, book reviews on sources already 
considered, publications not related to leprosy, and non-peer reviewed publications (e.g. 
letters). All publication dates were considered although some earlier dates were re-
evaluated for accuracy and relevancy. If articles had overlapping skeletal samples, the 
more recently published article was used. The earliest article with data used in this 
project (supplementary text Appendix B) was published in 1958 and the most recent 
article was published in June 2015. The literature search is up to date as of December 
2015. All documents returned from searches that were deemed relevant to this study are 
included in Appendix A. See Appendix B for articles/book chapters that were not 
included. Sources in all languages were considered and publications were found in 
English, French, Spanish, Danish, Hungarian, Russian, Ukrainian, German, Swedish, 
Czech, Croatian, Hebrew, Italian, Polish, Arabic, Portuguese, Japanese, Afrikaans, and 
Turkish.  
In a Microsoft excel document (Table 3), the details of the literature search was 
carefully organized under each database and sorted by search terms. More details about 
the results from the literature search are provided in the Results section (Chapter 4). From 
August-September 2015, each of the aforementioned databases were searched for 
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relevant articles using four search term combinations and their results counted. 
Additionally, the following topics were not included in the meta-analysis despite being 
related to the impact and exposure of M. leprae:   
• Articles describing signs and symptoms in living people, not skeletal signs, 
• Cases of leprosy that were non-human, 
• If cases of leprosy were mentioned but no description was given, 
• Only drug treatment for leprosy was described but without bone signs, 
• Articles reviewing cases already included from other sources, 
• Other diseases than leprosy were the primary focus of the article (leprosy only 
mentioned as an example). 
•  The total number of skeletons at the site, with and without leprosy, was not 
provided. 
“Not accessible” means that they could not be accessed by public domain or by 
the Boise State University library (see supplementary text Appendix B, column C). 
Useful articles that were not accessible were acquired either through inter-library loan or 
by contacting the author directly.  
The meta-analytic approach was developed in 1976 by Gene V. Glass to increase 
diagnostic accuracy and address methodological validity in statistical studies (Glass, 
1976). It is most often used to assess clinical effectiveness of healthcare or medical 
interventions by combining data from two or more randomized control trials (ex: BCG 
vaccine in regards to leprosy, Zodpey, 2007; Setia et al., 2006). Its use is not limited to 
clinical studies; systematic reviews and meta-analyses are possible and have been done 
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on paleopathological literature (Zweifel et al., 2009; Holloway et al., 2011; Setzer, 2014; 
Bratschi et al., 2015).  
As Rothstein and Hopewell (2009) noted in the Handbook of Research Synthesis 
and Meta-Analysis, “the aim of a high quality research synthesis is to generate as 
comprehensive a list as possible of both published and unpublished studies” (105). 
Similarly, Johnson and Eagly. (2014) recommend that “every effort should be made to 
obtain unpublished studies. Meta-analyses properly have the goal of describing the 
universe of studies on a topic or at least an unbiased sample of that universe” (682). This 
proved to be difficult for this study, although four relevant unpublished studies were 
acquired and used in this project. 
Geographic and Chronological Groupings: 
Cases were grouped into six regions: Northern Europe, Central and Western 
Europe, Mediterranean, Asia, Oceania, and New World. Within each geographical 
regions, cases were also organized by cultural time periods. These were termed “Bronze 
Age”, “Iron Age”, “Middle Age”, and “Early Modern Era.” The corresponding dates of 
these groups are listed in Table 1. Note, that the chronological term MA represents the 
Middle Ages, which refers to the same period of time as the medieval era.  
The European Middle (or medieval) Ages, listed in Table 1 as 1050 CE-1539 CE, 
is a major scheme for analyzing the crux of European history. However, the Post-
classical Era (e.g., any period that immediately follows ancient history), in China began 
with the start of the Sui dynasty (600 CE) and ended 100 years before Europe’s medieval 
ages (Marks, 2015:24). This seems to be the case for most of the rest of the Asian 
countries. Thus, the way these four periods were defined was somewhat restricted, yet out 
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of statistical necessity, some simplifications had to be made (Stone et al., 2009; Roberts, 
2002a; Boldsen, 2009).  
Table 1. Descriptions of temporal groups and the corresponding dates for each 
geographical region. Groupings based on information gathered from: Stone et al. 
(2009); Roberts (2002a), and Boldsen (2009) 
Geographical 
Region and 
Description  
(Total = 1,645) 
 
Bronze Age (pre-
600 BCE): Total 
Cases 
 
Iron Age (500 
BCE – 1050 CE): 
Total Cases 
 
Middle Ages 
(1050 CE-1536 
CE): Total Cases 
 
Early Modern Era 
(1536 CE – 1905 
CE): Total Cases 
Northern Europe  1 80 1,290 2 
Central and 
Western Europe 
2 39 137 0 
Asia 1 12 0 3 
Mediterranean 0 23 45 0 
New World 0 0 0 4 
Oceania 0 0 6 0 
 Total = 4 (0.24%) Total = 154 
(9.36%) 
Total = 1,478 
(89.9%) 
Total = 9 (0.55%) 
 
Distribution of Lesions 
Osteological lesions were recorded on the skeleton that were characteristic of 
leprosy. In this study, lesion distribution was based on facies leprosa-only (or 
rhinomaxillary syndrome), post-cranial only, or on both (facies leprosa and other) which 
acted as epithets to summarize the lesions reported in publications. These publications 
attributed their paleopathological system of lesions to Møller-Christensen (1978). More 
recent methodology is illustrated in Boldsen (2005, 2008, 2013), but the sequence 
remains practically the same as Møller-Christensen’s (Table 2). The term facies leprosa, 
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introduced by Møller-Christensen in 1952, serves to represent the following skeletal 
pathological changes of the skull: 
1. “Atrophy of the anterior nasal spine (ANS); 
2. Atrophy and recession of the alveolar process of the maxilla (APM) 
confined to the incisor region, beginning centrally at the prosthion and 
resulting in loosening and eventually loss of relevant teeth; 
3. Endonasal inflammatory changes. These endonasal inflammatory 
changes (ENIC) constitute the pathological basis of the complex, 
which should always be present for the diagnosis of “facies leprosa”, 
together with one or both of the other symptoms mentioned” (Møller-
Christensen, 1952, 1978). 
Table 2. Descriptions of leprosy lesions (Boldsen, 2008; Møller-Christensen, 
1952, 1978). 
Number Lesion Description 
1 The remodeling of the edge of the nasal aperture 
2 Atrophy of the anterior nasal spine 
3 Atrophy of the alveolar process on the premaxilla 
4 Porosity or perforation of the palate 
5 Subperiostal exostoses on fibula 
6 General hypertrophy of the fibula 
7 Changes to the plantar surface on the fifth metatarsal 
 
The distributions of lesions were compared using chi-square tests. Four 
contingency tables were created, each representing a different region, to test whether the 
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proportion of lesion type differed by time period. A Fisher’s exact test was calculated for 
each contingency table to deal with the small samples.   
Frequency of Lesions 
The frequency of lesions where sample size was known, was evaluated by 
dividing the total number of skeletons with leprosy lesions by the total number of 
skeletons at the site. This was not possible in all cases due to insufficient information 
(supplementary text Appendix B). For comparative purposes, a regression analysis was 
performed using linear, power, logarithmic, and exponential models (to determine which 
model fit the data best) to examine the frequency of leprosy at each site. The results were 
charted in histograms.  
Measurement of Variables 
Data Analysis 
The meta-analysis started with an exhaustive systematic review of the literature. 
The next research stage was setting boundaries for the sample of studies and selecting the 
determination criteria. After that, the third step was locating relevant studies, published 
and unpublished. Next, I created the meta-analytic database and decided on how the 
variables should be coded. A meta-analysis is the synthesis of compatible effects, giving 
greater weight to studies with less variance and more precision (Kovalchik, 2013). This 
project analyzed data using the R software (cran.r-project.org).  
I used the R package metaprop to examine how proportions of leprosy varied 
across different time periods. By examining the forest plots, I inspected whether there 
was a trend in proportion of leprosy skeletons by time period. Chi-squared tests were also 
examined to determine if a) the proportion of leprosy between the different geographical 
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regions varied; b) the proportion of leprosy varied between the BA, IA, MA, and EME 
individuals; and c) if the distribution of lesions between four of the six geographical 
regions varied. Since the expected value of cells fell below 5 in at least one cell of each 
contingency table, Fisher’s exact test was used to determine if there were differences in 
the proportions between the groups. 
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CHAPTER FOUR: RESULTS 
Sample Size 
A literature search conducted from August to September 2015 from 10 academic 
databases using a combination of four search terms (see Table 3) returned a combined 
total of 21,641 references. After additional searches (by searching through particular 
journals, for instance), the total number of references totaled 21,880. Of these references, 
77 met the inclusion criteria, 73 published and 4 unpublished (see Chapter 3).  
Every continent, except Antarctica, had data, although the data varied drastically 
in quantity. The exact number of leprosy cases reported across 77 papers was 1,645 from 
a total number of 102 gravesites. Additionally, 533 of these individuals were sexed and 
1,112 were unable to be sexed or the sex was not provided. From these 102 gravesites, 
there was a total number of 18,787 skeletons excavated. Thus, the percentage of 
individuals showing osteological signs of leprosy expressed in relation to total number of 
individuals is 8.76%.   
A few search term options were explored to determine the best choice to narrow 
down the search and ultimately, the combination “leprosy AND paleopathology” was 
deemed most responsive for acquiring relevant references. The other search 
combinations, listed in Table 3 and discussed in the next paragraph, were searched as 
well, but most relevant articles overlapped with any found in the “leprosy AND 
paleopathology” combination, and therefore these search terms were not used. In all, 
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2,104 articles were returned from the search term combination “leprosy AND 
paleopathology.” These articles were read and organized by database and relevance.  
An additional 107 articles were found via references from papers included in the 
study, even though these articles were not found through a database. An additional 58 
references were found not through a database, but they were categorized as “not 
accessible” (supplementary text Appendix B, column C). In an excel document, all 1,661 
articles found through databases were read to determine if they were “useful” or 
“somewhat useful” to the project. 208 references were deemed “useful,” 232 references 
were deemed “somewhat useful,” and 1,221 references were deemed “not useful.” 
“Useful” references contained data that was used in this project, whereas the “somewhat 
useful” references were primarily used for supporting information.  
In every database listed after the first one (for example, ProQuest; see 
supplementary text Appendix B, row 980), there is a column added on whether the article 
is a duplicate or “new to the search”. It is a “NO” if it is a duplicate and is a “YES” if it is 
not a duplicate. In column D, those that were repeats contained “Repeat” in the row. The 
results from Google Books, in all four search combinations, revealed similar results to 
those found in Google Scholar. Thus, the references from Google Books are not included 
in the Microsoft Excel document (supplementary text Appendix B).  
After the literature search was completed, 432 references were removed as 
duplicates, 1,221 yielded no relevant information, and 555 were not accessible. “Not 
accessible” means that they could not be accessed by public domain or by the Boise State 
University library. Most of these “not accessible” articles were either repeats or not 
relevant to the study according to its abstract. Useful articles that were not accessible 
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were acquired either through inter-library loan or by contacting the author directly. Refer 
to Table 3 for details on the literature search. Additionally, 107 publications were 
acquired by following up references from papers included in the study and 13 were 
received from Dr. Charlotte Roberts, Dr. Helen D. Donoghue, Dr. Joel Blondiaux, Dr. 
Francisco J. Silva, and Dr. Kristin Snopkowski. 
Table 3. Details on the literature search from mentioned databases. Completed 
December 2015  
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Figures 2 and 3 show histograms charting the number of leprous skeletons at each 
site (referred to as ‘Events’ for here on) and the total number of skeletons at each site 
(referred to as ‘Total’ for the remainder of the thesis). Both figures do not have a normal 
distribution and produced very positively skewed data. This indicates that the majority of 
sites have small samples (both in the number of leprous skeletons and the total number of 
skeletons), while a few sites have large sample sizes. A Shapiro-Wilk test shows that 
these distributions are non-normal; Events (W = 0.2248, p < 0.001) and Total (W = 
0.7324, p < 0.001). A histogram of proportion of Events at each site (Figure 4) also 
shows that the proportion data is not normally distributed, although most sites have less 
than 10% leprous skeletons.  
 
Figure 2. Histogram overlaid with a normal curve of density (y) to number of 
Events (x) where Events represents number of leprous individuals at a site 
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Figure 3. Histogram overlaid with a normal curve measuring density (y) the 
distribution of the Total (x) number of skeletons at each site 
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Figure 4. Histogram of the proportion of leprosy skeletons at each site  
Sex 
The sample is composed of 312 males (59%) and 221 females (41%) (Figure 5). 
In this study, M represents males, F represents females, U represents those with unknown 
sex, and NA represents individuals where sex was not reported. Combined, sexed 
skeletons only amounted to 32.4% of the total sample. Those that were unknown or not 
reported cumulated 67.6% of the total (combined distribution depicted in Figure 6). 
Sexing was not possible for most individuals less than 18 years old (“infants” and 
“juveniles”) and are placed in the unknown category.  
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Figure 5. Number of males and females (only for those reporting sex, N = 533) 
 
Figure 6. Number of males, females, unknown, and not reported (N = 1,645) 
Age 
Age at death categories follow the organization used by Møller-Christensen 
(1978). The age composition of the study sample were sorted into these eight categories: 
Males, 312, 59% 
Females, 221, 
41% 
LEPROUS SKELETONS: MALE AND FEMALE 
Males Females
19% 
13% 
3% 
65% 
DIVISION OF TOTAL SKELETON BY SEX 
Males Females Unknown Not Reporting
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0-6 years old, 7-13 years old, 14-19 years old, 20-29 years old, 30-39 years old, 40-49 
years old, 50-59 years old, and 60+ years old. Some references did not report the exact 
estimated age of death, using monikers such as adult, young adult, elderly, adolescent, 
and middle-aged.  In those cases, an age was estimated: adult (40 years old), young adult 
(25 years old), elderly (65 years old), adolescent (14 years old), and middle-aged or 
mature (50 years old). The age composition with (N = 611) and without (N = 428) the 
estimated ages included are combined in Table 5. 
The average ages of death of the total sample, male only, female only, and 
unknown only were also calculated. In some instances, the average age of death fell 
below the other estimates, so averages excluding 0-6 years and 7-14 years values were 
also incorporated in Tables 4, calculating an average that did not account for instances of 
child mortality.  
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Table 4.  Average ages of study sample – with estimation of terminology on the 
left and without estimation on the right. ‘Adults’ are assumed to be 40 years old, 
‘young adults’ are 25 years old, ‘middle-aged adults’ and ‘mature’ are 50 years old, 
‘elderly’ adults are 65 years old, and ‘adolescents’ are 14 years old. M stands for 
male, F stands for female, and U stands for unknown 
Average ages of all eight 
groups 
With estimated-aged 
skeletons included 
Without estimated-aged 
skeletons included 
Total 29.91 30.76 
M Only 34.02 34.27 
F Only 38.03 38.4 
U Only 27.33 22.9 
Excluding individuals less than 14 years old 
Total 37.65 38.77 
M Only  37.73 38.02 
F Only 38.03 38.4 
U Only) 41.12 39.15 
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Table 5. Age composition within the study sample – includes the distribution 
with and without estimated ages, where ‘adults’ are assumed to be 40 years old, 
‘young adults’ are 25 years old, ‘middle-aged adults’ and ‘mature’ are 50 years old, 
‘elderly’ adults are 65 years old, and ‘adolescents’ are 14 years old 
 With estimated-
aged skeletons 
included 
 Excluding 
estimated-aged 
skeletons 
 
Age category Number of 
skeletons 
Percent of total Number of 
skeletons 
Percent of total 
0-6 4 0.65% 4 0.93% 
7-13 21 3.44% 21 4.90% 
14-19 51 8.35% 50 11.68% 
20-29 35 5.73% 34 7.94% 
30-39 137 22.42% 137 32.00% 
40-49 187 30.60% 15 3.50% 
50-59 156 25.53% 149 34.81% 
60+ 20 3.27% 18 4.20% 
Total 611 100% 428 100% 
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Does Frequency of Leprosy Lesions Change through Time? 
The frequency of leprosy lesions at each burial site (Table 6) was plotted by time 
(measured in years BP). Figure 7 includes all time periods in years BP (N = 95) whereas 
Figure 8 excludes Bronze Age (BA) lesions (N = 92). Figure 8 excluded BA skeletons 
because those values were outliers. In both figures, the best-fit line and the r2 fit statistic 
are presented. Both figures show an upward trend in the frequency of leprosy lesions at 
each burial site through time. Figure 7, which includes all skeletal data, demonstrates that 
leprosy frequency is slowly increasing throughout the BA and IA, but drastically 
increases around 1000 BP. Figure 8, by excluding the BA skeletons, shows the upward 
trend clearly, with a large cluster of skeletons dating from 1000 BP to 500 BP.  
 
Figure 7. Frequency of leprosy lesions at each burial site to time period in BP 
(N = 95). Includes Bronze Age skeletons. The x-axis is years BP in 500 year intervals 
and the y-axis is the frequency of leprosy at a site in intervals multiplied by two and 
includes the power function trend line 
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Figure 8. Frequency of leprosy lesions at each burial site to time period in BP 
(N = 92). Does not include Bronze Age skeletons. Both axes are plotted as natural 
logarithms and includes the power function trend line  
Lesion Distribution 
Lesions 
Ninety-five out of 102 sites (93%) of the references that met the inclusion criteria 
of the survey reported leprosy lesion type. Osteological changes indicative of leprosy 
were recorded in seven locations on the skeleton (Table 2) (Boldsen, 2008; Møller-
Christensen, 1952, 1978). Most references utilized the osteological method of reporting 
leprosy lesions developed by Møller-Christensen in 1978. Since not all the articles 
utilized a seven-step system, three monikers were used that broadly segregate the 
different types: facies leprosa (also known as skull-only), post-cranial-only, and both. 
Lesion count of each site based on these three types are recorded in Table 6.  
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Does Distribution of Lesions Change over Time? 
To examine the relationship between the proportions of lesions across different 
time periods, a Fisher’s exact test was conducted. A Fisher’s exact test is a non-
parametric version of the chi-square test and was conducted because the assumption of 
expected value greater than five was not met. The Fisher’s exact test produced a p-value 
<0.001 indicating that there is a significant difference in leprosy distribution across time. 
Table 6. Lesion distribution total (N = 301), based on facies leprosa-only (or 
face-only), post-cranial only, or on both (facies leprosa and other). BA is Bronze 
Age, IA is Iron Age, MA is Middle Age, and EME is Early Modern Era 
Lesion-Type BA IA MA EME 
Face-Only 0 34 45 1 
Post-Cranial Only 0 4 56 1 
Both 1 13 140 6 
 
How does the Proportion of Lesion Type Change across Time Period? 
Next, a Fisher’s exact test was conducted to examine the relationship between the 
proportion of lesion types and time. There was a significant relationship between the 
number of lesions in each category across region and time, with a p-value<0.001 
indicating a significant difference in these lesion distributions across time. Therefore, the 
distribution of lesions is changing over time from both types to facies-leprosa back again 
to both types. 
Does Lesion Type Change through Time by Region? 
Four contingency tables consisting of the number in each lesion type in each time 
period were made to conduct tests by geographical region: Northern Europe, Central and 
Western Europe, Mediterranean, and Asia (Tables 7A, 7B, 7C, and 7D). There were no 
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specific place of lesions indicated in any Oceania samples and the New World skeletons 
were only found in the Early Modern Era (EME) so only four contingency tables were 
made. Northern Europe had the largest amount of leprosy lesions (N = 203) in all, with 
66.1% falling under MA Northern European skeletons with both lesion-types. There were 
only 22 Central and Western European skeletons with lesions, 45% of whom dated to the 
IA and only had facies leprosa. There were 59 Mediterranean skeletons with lesion-types, 
primarily facies leprosa only in the IA and the MA. In Asia, 69% of the 13 total skeletons 
with lesions were from the IA with facies leprosa and 2 EME Asian skeletons had both 
lesion-type. Fisher’s exact tests determined that, out of the four geographic areas tested, 
only Asia was significant. See Chapter 5 for further discussion on the results from Tables 
7A-D.  
Table 7A.  Contingency table of Chi-square test measuring lesion types – 
Northern Europe 
Lesion-Type IA MA EME 
Face-Only 1 5 0 
Post-Cranial Only 3 55 1 
Both 3 134 1 
Fisher’s Exact Test: p-value = 0.1596 
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Table 7B. Contingency table of Chi-square test measuring lesion types – Central 
and Western Europe 
Lesion-Type IA MA 
Face-Only 10 4 
Post-Cranial Only 1 1 
Both 5 1 
Fisher’s Exact Test: p-value = 0.7988 
Table 7C. Contingency table of Chi-square test measuring lesion types – 
Mediterranean 
Lesion-Type IA MA 
Face-Only 14 36 
Both 4 5 
Fisher’s Exact Test: p-value= 0.434 
Table 7D. Contingency table of Chi-square test measuring lesion types – Asia 
Lesion-Type BA IA EME 
Face-Only 0 9 0 
Both 1 1 2 
Fisher’s Exact Test: p-value = 0.014 
Tables 8 and 9 chart mean age at death by male, female, unknown and total across 
the four time periods. Table 8 provides calculated average age with estimated 
terminology of age included whereas Table 9 provides averages without the terminology 
included.  
Figures 9 and 10 consist of the same information as Tables 8 and 9 but categorize 
average ages by geographical region as well. All 8 age categories are not represented in 
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some geographical regions and thus, have N/A next to it. Figure 9 includes results with 
the estimated terminology of age and Figure 10 excludes those results. 
Table 8. Frequency distribution of median age at death for each time period in 
the combined sex sample – with estimated terminology (N = 611). Numbers in 
parenthesis represent the number of each calculated for each average 
 
 
Table 9. Frequency distribution of median age at death for each time period in 
the combined sex sample – without estimated terminology (N = 424). Numbers in 
parenthesis represent the number of each calculated for each average 
 
 
Two multi-way ANOVA’s were conducted to see whether age is significant by 
groups: sex (M, F, and U) and time period (BA, IA, MA, and EME). Levene’s test was 
used to test for homogeneity of variance. The Levene’s test for Figure 9, which includes 
data with estimated terminology, was significant (D.F. =11, F-value=5.37, p-
Calculated Average Age at Death for Each Time Period: With Estimated Terminology:
Average 
Culmulated Age 
(and number of 
each)
Average Male Age 
(and number of 
each)
Average Female 
Age (and number 
of each)
Average Unknown 
Age (and number 
of each)
Bronze Age: pre-600 BCE 26.625 (4) 28.5 (2) 42.5 (1) 7 (1)
Iron Age: 500 BCE - 1049 CE 38.29 (67) 39.5 (30) 38.66 (18) 36.04 (19)
Middle Ages: 1050 CE - 1535 CE 37.25 (530) 40.75 (193) 33.87 (170) 36.47 (167)
Early Modern Era: 1536 CE - 1905 CE 36.44 (8) 35.8 (5) 22.5 (1) 45 (2)
Calculated Average Age at Death for Each Time Period: Without Estimated Terminology:
Average 
Culmulated Age 
Average Male Age 
(and number of 
Average Female 
Age (and number 
Average Unknown 
Age (and number 
Bronze Age: pre-600 BCE 26.625 (4) 28.5 (2) 42.5 (1) 7 (1)
Iron Age: 500 BCE - 1049 CE 35.9 (35) 37.07 (22) 38.03 (11) 2.43 (2)
Middle Ages: 1050 CE - 1535 CE 36.87 (378) 40.65 (185) 33.76 (167) 16.98 (26)
Early Modern Era: 1536 CE - 1905 CE 34.5 (7) 32.25 (4) 22.5 (1) 45 (2)
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value=<0.001), suggesting the assumption of homogeneity of variance is not met. The 
ANOVA in Figure 9 states that, with the estimated terminology included, sex by itself is 
significant (p<0.001) but time period by itself as well as the combination of sex and time 
period together are not significant (p=0.26; p=0.13). 
Additionally, the Levene’s test for Figure 10, which does not include data with 
estimated terminology, is also significant (DF=11, F-value=1.85, p-value=<0.05). The 
ANOVA in Figure 10 states that, without the estimated terminology included, sex by 
itself is significant (p<0.001) but time period by itself is not significant (p=0.55). 
However, sex and time period together are significant (p<0.01).  
These results suggests that the sex (M, F, and U) of the leprous skeletons is a 
significant factor to the age at death whether estimated terminology was used in the 
ANOVA or not. Time period was a significant factor to the age at death only when 
combined with sex and only when estimated terminology is not included (Figure 10). 
Since the culminated average ages at death between the four time periods only varied 
slightly, it is apparent that sex would need to be significant for the ANOVA’s to be 
significant.  
 
Figure 9. Multi-Way ANOVA of median age at death for each time period and 
geographical region in the combined sex sample – includes estimated terminology of 
age (N = 611) 
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Figure 10. Multi-Way ANOVA of median age at death for each time period and 
geographical region in the combined sex sample – does not include estimated 
terminology of age (N = 412) 
Does the Proportion of Leprosy Skeletons per Site Change? 
Leprosariums likely affect the proportion of leprous individuals in the study. 
Table 10 lists the 13 leprosariums used in this study and Table 11 lists the 4 leprosariums 
that were not included in the data since they did not include the total number of skeletons. 
While leprosariums are crucial in bioarchaeology, the overall representation of leprosy’s 
effect was skewed towards those sites with leprosariums. In particular, the data found at 
three leprosariums in Denmark made up 69% of this data’s total number of leprous 
individuals. Figures 12 and 13 show two forest plots arranged chronologically by date 
and time period, respectively, that excludes all leprosariums and samples less than 10 
individuals (total) Leprosariums are further discussed in Chapter 5. 
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Table 10. Leprosariums used in the study organized by date (N = 13) 
 
 
Table 11. Leprosariums that were not used in the study organized by date (N = 
4) 
 
 
References Leprosarium Year (Mid-point)
Mendum et al (2014); Magilton et 
al (2008)
St. Mary Magdalen, Winchester, 
UK 1043 CE
Wells (1967) Castle Acre, Norfolk, UK 1225 CE
Blondiaux et al (2015)
Saint-Thomas d’Aizier, Haute-
Normandy, France 1250 CE
Chundun et al (1995) St. Giles, North Yorkshire, UK 1290 CE
Manchester et al (1986) 
St. Mary and St. Thomas hospital, 
Ilford, Essex, UK 1300 CE
Farley et al (1989)
St. Margaret’s Hospital, 
Buckinghamshire, UK 1350 CE
Primeau et al (2014) Maribo, Lolland, Denmark 1350 CE
Lee et al (1989); Magilton et al 
(2008)
St James and St Mary Magdalene, 
Chichester, UK 1388 CE
Antunes-Ferreira et al (2013) Beja, Portugal 1400 CE
Møller-Christensen (1978) 
St. Jorgen Hospital, Næstved, 
Denmark 1400 CE
Boldsen (2001) 
Kvarteret S:t Jörgen leprosy hospital, 
Malmö, Skåne, Sweden 1420 CE
Jensen et al (1983) St. Jørgen, Odense, Denmark 1450 CE
Ferreira et al (2013) Lagos, Algarve, Portugal 1500 CE
References Leprosarium Year (Mid-point)
Schultz et al (2002) Lihou Island, Guernsey, UK 1250 CE
Bishop (1983) St. Leonard’s, Nottinghamshire, UK 1350 CE
Matos et al (2013) 
St. Jørgen leprosarium cemetery, 
Odense, Denmark 1350 CE
Schmitz-Cliever (1972) Aachen, Germany 1390 CE
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Three forest plots (Figures 11, 12, and 13), which serves as a graphical 
representation of a meta-analysis, describe the meta-analysis of overall proportion from 
studies reporting a single proportion using the package ‘metaprop.’  The prevalence is 
measured based on the proportion of leprous skeletons at the site (N = 3,978). One forest 
plot (Figure 11) excludes any “Totals” under 10 so small sample sizes did not affect the 
data but includes data from leprosariums (listed in Table 10). The second forest plot 
(Figure 12) also excludes data taken from leprosariums, given that these may 
overestimate the prevalence of leprosy, in order to see how the proportions of leprosy 
skeletons changed through time.  
The last forest plot (Figure 13) takes the data used in Figure 12 and organizes it 
by region instead of by date. Therefore, two forest plots are ordered chronologically by 
date whereas the last forest plot is organized chronologically by geographic region. This 
will demonstrate what factor influenced heterogeneity the most or if at all. Heterogeneity, 
which examines the amount of variation that exists between studies, was tested in order 
to determine the likelihood that the rates of leprosy prevalence were either changing over 
time or by geographic region. Greater levels of heterogeneity suggest that the samples are 
not consistent across time or place (Chen and Peace, 2013). If neither time period nor 
geographic region affect heterogeneity, then there is an unknown factor influencing the 
rate of leprosy.  
The first forest plot had fixed and random effect proportions of 0.35 (I2=98.6%; 
T2=2.4; p<0.0001), indicating a significant difference in proportion across the 16 studies 
in the meta-proportion. The second and last forest plots have fixed effect and random 
effect proportions of 0.20 and 0.21 (I2=94.4%; T2=0.7043; p<0.0001), suggesting a 
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slighter smaller difference in heterogeneity between the 10 studies in this meta-
proportion than the first plot. Therefore, running a meta-proportion that included 
leprosariums had more heterogeneity than a meta-proportion that was conducted without 
them, as expected. The heterogeneity tells us whether there are significant differences 
between those proportions. 
The sites with the largest proportion of leprosy were found at leprosariums 
(Studies 3, 10, 12, and 16 in Figure 11). By removing those sites, the highest proportion 
is in St. Nicholai Kirche in Schleswig Germany at 44% versus the highest proportion of 
95% at St. Jørgen, Denmark when leprosariums are included. Additionally, Figures 11 
and 12 do not show a clear trend of proportion in those sites dating to the Iron Ages 
versus the medieval aged sites, suggesting that proportion is independent of time period.  
 
Figure 11. Forest plot of a meta-analysis of single proportions. Excludes Events 
under 10 but includes leprosariums. Organized chronologically by date where Study 
1 occurred furthest back in time and Study 16 most recently. Studies: 1 (478 CE; 
Lauchheim, Germany), 2 (950 CE; St. John, Norfolk), 3 (1043 CE; St. Mary 
Magdalen, Winchester), 4 (1050 CE; St. Nicolai Kirche, Schleswig, Germany), 5 
(1050 CE; St. Clemens Kirche, Schleswig, Germany), Study 6 (1065 CE; Lund, 
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Sweden), Study 7 (1133 CE; Rathaus Markt, Schleswig, Germany), 8 (1239 CE; 
Dominikaner Kloster, Schleswig, Germany),  9 (1250 CE; Tirup, Denmark), 10 
(1250 CE; Saint-Thomas d’Aizier, France), 11 (1388 CE; St. James and St. Mary 
Magdalene, Chichester), 12 (1400 CE; St. Jorgen, Denmark), 13 (1420 CE; Malmö, 
Denmark), 14 (1410 CE; St. Knud, Odense, Denmark), 15 (1410 CE; St. Albani, 
Odense, Denmark), 16 (1450 CE; St. Jørgen, Denmark) 
 
Figure 12. Forest plot of a meta-analysis of single proportions. Excludes Events 
under 10 and leprosariums. Organized chronologically by date where Study 1 
occurred furthest back in time and Study 10 most recently. Studies: 1 (478 CE; 
Lauchheim, Germany), 2 (950 CE; St. John, Norfolk), 3 (1050 CE; St. Nicolai 
Kirche, Schleswig, Germany), 4 (1050 CE; St. Clemens Kirche, Schleswig, 
Germany), 5 (1065 CE; Lund, Sweden), 6 (1133 CE; Rathaus Markt, Schleswig, 
Germany), 7 (1239 CE; Dominikaner Kloster, Schleswig, Germany), 8 (1250 CE; 
Tirup, Denmark), 9 (1410 CE; St. Knud, Odense, Denmark), 10 (1410 CE; St. 
Friars, Odense, Denmark) 
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Figure 13. Forest plot of a meta-analysis of single proportions organized 
temporally by region. Excludes Events under 10 and leprosariums. Organized by 
geographic region where Studies 1 through 5 represent Central and Western 
Europe and Studies 6 through 10 represent Northern Europe. Studies: 1 (478 CE; 
Lauchheim, Germany), 2 (1050 CE; St. Nicolai Kirche, Schleswig, Germany), 3 
(1050 CE; St. Clemens Kirche, Schleswig, Germany), 4 (1133 CE; Rathaus Markt, 
Schleswig, Germany), 5 (1239 CE; Dominikaner Kloster, Schleswig, Germany),  6 
(950 CE; St. John, Norfolk), 7 (1065 CE; Lund, Sweden), 8 (1250 CE; Tirup, 
Denmark), 9 (1410 CE; St. Knud, Odense, Denmark),  10 (1410 CE; St. Friars, 
Odense, Denmark) 
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CHAPTER FIVE: DISCUSSION 
Does Bone Lesion Type Vary by Time Period? 
The frequency and distribution of bone lesions was found to vary depending on 
the geographical region and time period. All regions except for the New World, saw a 
rise in bone lesions after the Bronze Age but significantly decreasing after the Middle 
Ages (Tables 7A-D). This finding suggests that leprosy’s large prevalence in most 
medieval, non-New World countries correlates with the poor health and high frequency 
of disease before the Early Modern Era. The New World only had bone lesions found 
post-1536 CE, which corresponds to other research made by comparative genomic 
studies that leprosy entered the Western hemisphere after the medieval period. The only 
significant result came from Asia, proposing that Asian bone lesions proportions varied 
by time period from both to facies-leprosa to both. No significant differences were found 
between the proportions of bone lesions across time for the other three geographical 
regions.  
Additionally, the values of the chi-square test measuring lesion distribution 
suggests that there are significant differences in proportion of lesion types by time 
periods (BA, IA, MA, and EME) and geographic regions (NE, CWE, M, A, NW, and O). 
Skeletons from Northern Europe in the medieval ages are more likely to display both 
lesion types than facies-leprosa or post-crania only. Skeletons from Central and Western 
Europe in the Iron Age has a greater proportion of facies-leprosa. Skeletons from 
medieval Mediterranean countries have a greater proportion of facies leprosa, and Iron 
Age Asia has a greater proportion of facies leprosa (Tables 7A-D). This suggests that 
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different parts of the world suffered from either tuberculoid or lepromatous leprosy, 
which affects different parts of the body. Additionally, some results are biased towards 
one type since there were skeletons that were missing parts of their body, either due to 
poor preservation or to burial preference (i.e., ossuary jars in the Czech Republic). 
How Does the Rate of Leprosy Change over Time? 
Two of the forest plots (Figure 11 and 12) were organized by time to see if there 
was a trend of proportions through time while one (Figure 13) was organized 
chronologically by region. The studies with the highest proportions of leprosy came from 
were from leprosariums (Figure 11), such as the St. Mary Magdalen leprosarium in 
Winchester, UK and the Saint-Thomas d’Aizier in France. When the leprosariums were 
removed from the data and put in new forest plots, the sites with the highest proportions 
were all from Schleswig, Germany. 
Organizing by region did not change the proportion values in the forest plot, 
predictably, but displayed the pattern the proportions made by region instead of time 
period. Notably, Figure 12, which is organized by date, shows a larger frequency of sites 
from the 11th and 12th centuries to any other time period. Even without leprosarium data 
included, this suggests that leprosy was prevalent in the early to middle medieval ages. 
Geographically, Figure 13 has a large proportion of non-leprosarium sites from 
Schleswig, Germany and Tirup, Denmark (Studies 2, 3, 4, 5, 8; Figure 13) (Boldsen et 
al., 2013; Boldsen, 2005b). Denmark has always been well-represented in leprosy during 
the medieval period, but this finding from Germany is unique. Possibly, Schleswig, 
Germany did not act as a leprosarium but as a town for leprosy sufferers and non-leprosy 
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sufferers alike could live together and be buried together. More data on this topic is 
required, however. 
As for the rest of the data, the forest plots show that Denmark had large cases 
(10+) of leprosy throughout the 13th and 14th centuries whereas other countries that were 
represented early on in the forest plot with large leprosy cases – UK, Germany, and 
Sweden – had decreased in frequency. Based on the chronological and temporal 
distribution of these sites with 10+ leprosy cases (excluding leprosariums), leprosy was 
prevalent throughout Europe but did not impact Denmark until the 13th century, after it 
had decreased everywhere else.   
Demographics 
Leprosy more commonly occurs in males, who are more susceptible to the 
disease, than females in most regions of the world, although leprosy can affect all age 
groups (Walker, 2009:364). The data set confirms this, as 312 male skeletons had leprosy 
whereas only 221 females had it. Individuals under 18 years old and over 60 years old 
were poorly represented in the sample, likely because it takes years to develop bone 
lesions but most will not survive over the age 60 (Lynnerup and Boldsen, 2012). 
Although all age groups were represented, this infectious disease is not spread equally 
among the age groups. Based on the information from Table 8, or with the estimated 
terminology, the average cumulated ages ranged from 26.6 years to 38.3 years whereas 
the average cumulated ranged from 26.6 years to 36.9 years without estimated 
terminology factored in (Table 9). Subsequently, providing an estimate of age for those 
reported as adult, middle-aged, young adult, adolescent, and elderly did not change the 
numbers drastically. Tables 8 and 9 also show that males lived longer in the medieval era 
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than any other time period (40.75 years or 40.65 years) whereas females lived their 
longest in the Bronze Age (42.5 years) although this might be due to the small sample 
from the BA. While this demographic information is significant and suggests variation in 
health and sex-roles through time, the values are not significantly different from one 
another so a conclusion about age at death and sex can be made.  
When the estimated terminology is included, 40-49 year old adults comprise the 
largest portion of the eight age groups (N = 187). This is likely because 173 of those 
numbers were “adults” of unknown age, subsequently estimated to be 40 years old. The 
appellative “adults” is a common term to call an older skeleton when age is generally 
unknown but the range could be anywhere between 20 to 60 years. With an estimation of 
40 years for these 173 “adults,” the distribution is predictably skewed towards a large 
number of 40 year olds in the sample. Most likely, based on historical information of the 
time period, the average age at death for those suffering from leprosy would have ranged 
anywhere from 30 to 39 years old (Blondiaux et al., 2015; Boldsen, 2005; Weiss and 
Møller-Christensen, 1971), a result that is confirmed by the paleopathological skeletons 
used in this study (see Table 5, which includes and excludes data where age was 
estimated by this project’s author). 
Health 
Out of all the 1,645 leprosy cases used in this study, 0.24% were from the BA, 
9.4% were from the IA, 89.9% were from the MA, and 0.55% were from the EME. There 
was an decrease in prevalence rates from BA (7.02% of cases from that time period) to 
IA (1.95% of cases from that time period) then a drastic increase in the MA (14.2% of 
cases from that time period) then a drop in cases in the EME (2.1% of cases from that 
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time period). Roberts (2002a) attributes MA’s large increase in leprosy cases to denser 
living conditions and decreased sanitation, stimulating the rate of transmission.  
There is a steep decline in prevalence rates once the medieval period came to an 
end in the 16th century likely due to the aftermath of the Black Death and increased 
competition with TB. Skeletal evidence of chronic infectious disease, according to Larsen 
(2009), “are primarily associated with agricultural-based populations living in close, 
densely crowded communities” (2009:7). It is assumed that, due to a rise in population, 
skeletons dating to the Iron Age, Middle Age, and Early Modern Era were from densely 
populated, agricultural communities. Agriculture was a relatively new phenomenon to the 
Bronze Age skeletons so it is possible that small number of skeletons in the dataset (N = 
4) is related to agriculture’s recent introduction. An agriculture-based diet is less healthy 
and more labor intensive than a hunter-gatherer diet. It also creates densely-populated 
areas, promoting the spread of disease. 
A trend observed in the data was that females died at a younger age than males in 
all time periods except the Bronze Age (Tables 8 and 9). This finding is significant 
because assessing age at death and sex portrays the health conditions and trends of the 
population in a given time and place. In contrast to the pattern seen today where females 
live longer than males, a significant proportion of women in the Iron Ages and medieval 
ages died in association with childbirth. Life expectancy varied by location, but the trend 
remained the same. In the mid-late medieval UK, for example, the average life 
expectancy at birth for an aristocratic male was around 35 years whereas a female at birth 
was expected to live to age 30 (Lancaster, 1990:8). Surprisingly, the average ages for 
leprous individuals of both sexes in the data fall within 30 to 40 years, matching 
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estimates of the life expectancy at birth for the time period. This could be because 
leprosy, while a disfiguring disease, does not cause death unless it co-infects the 
individual with other diseases. In this dataset, the average age at death is higher than life 
expectancy at birth in the mid-late medieval UK because not many infants/children are 
dying with leprosy, whereas there were likely higher rates of infant/child mortality in the 
general population. Those children that did die from leprosy would skew that data 
towards a lower average age of death, a trend that is observed for the “unknown” 
individuals in Table 4. Assessing the average age of death is affected by the 
“Osteological Paradox,” since many children do not have time to develop telling bone 
lesions before they die. 
In reality, these estimates of life expectancy are at birth but once a person 
survives the first few years of life, life expectancy goes up by many years. A 21-year old 
individual’s life expectancy in 13th century UK is 64 years. Therefore, it is also 
reasonable to conclude that the individuals in the dataset did not outlive non-infected 
individuals who, if they lived past the first few years of life, could expect to live well into 
their 50s and 60s. The leprosy sufferers usually died at an average age of 35 to 40 years 
of age. 
However, life expectancy for the general population and those suffering from 
leprosy dropped drastically in the 1300-1400s, reflecting the high mortality rates caused 
by the Black Plague (see Chapter 1). A 21-year old aristocratic male in the UK was only 
expected to survive an additional 25 years in the 14th to 15th centuries (Lancaster, 1990). 
Therefore, the average age of death of a non-leprous individual and a leprous individual 
during the 1300-1400s were almost the same.  
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Leprosariums 
Since successful medical treatment for leprosy did not exist until recently, past 
efforts focused on segregating and caring for those individuals afflicted with the disease. 
Leprosariums became common during the medieval era, often existing outside the city 
limits (Covey, 2001:320). Historical reports relaying accurate numbers of leprosariums at 
a given time vary drastically. Roffey (2012) reports “over 300 documented leper 
hospitals in the medieval period” (2012:203). Meanwhile, Matthew of Paris, a medieval-
era Benedictine monk, roughly estimated there to be more than 19,000 “lazar houses” in 
Europe in the eleventh century (Simpson, 1872:3).  
Estimates for the leprosarium count also differ depending on the country. Covey 
(2001) reports that by the mid-12th century CE, France had around 2,000 leprosariums, 
although there are none from that time period used in the dataset for this thesis, while 
England and Scotland had about 220 leprosariums (2001:317). Denmark had 31 
leprosariums between 1250 CE to 1550 CE (Bennike et al., 2005). In Portugal, there were 
around 70 small leprosariums during the medieval period (Antunes-Ferreira et al., 
2013:149; Carvalho, 1932). Likely, Covey states, there was a misuse of the word 
“leprosarium” for hospitals that treated people with leprosy occasionally, exclusively, 
sometimes, or never at all (2001:317; Roffey, 2010:217; Rogers et al., 1946). 
Due to this misrepresentation of terminology, opinions vary in the literature on 
the prevalence of leprosy in medieval Europe. For the most part, authorities of the period 
agree that leprosy was a familiar disease during the 11th to 15th centuries among 
Europeans, as the disease is consistently reported and referred to in medieval-aged texts. 
It is intriguing to see the contrast between the reported number of leprosy hospitals and 
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the cases seen in the bioarchaeological record. This could indicate that leprosy was over-
reported in the historical literature, possibly confusing the disease for another pathogen. 
It is interesting, although not surprising given the historical literature, that every 
leprosarium, save one, whether its data was used in the study or not, dates to the medieval 
era (1050 CE – 1536 CE). The only exception is St. Mary Magdalen in Winchester, UK, 
although at 1043 CE only makes this site seven years away from the MA cut-off. While 
the bioarchaeological record may not show it, Antunes-Ferreira et al. (2013) states that 
leprosy hospitals were around in Europe as far back as 5th century CE (149). 
These results also show leprosariums in the paleopathological literature were only 
in Europe, primarily in the UK and Denmark. This is unsurprising as the only non-
European paleopathological skeletal sites from the medieval period used in this study 
were in Polis Chrysochous, Cyprus, Dakhleh Oasis, Egypt, and western Micronesia for a 
combined total of 11 non-European medieval-aged individuals (Baker et al., 2014; Molto, 
2002; Trembly, 1995). Out of a total 1,108 burials from these three sites, these 11 leprous 
individuals indicate a rate of leprosy in non-European MA to a paltry 0.992% according 
to this paleopathological data. In this regard, these results support studies suggesting 
Mycobacterium leprae and leprosariums primarily raged through Europe during the 
medieval era although this conclusion could be biased based on where bioarchaeological 
research occurs (Donoghue et al., 2005, 2015; Matheson et al., 2009; Robbins et al., 
2009). 
Transmission and aDNA 
Comparative genomic studies have mapped genetic variability between 
populations through mapping SNP-types and variable number tandem repeat, or “VNTR” 
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types. “SNP” or single nucleotide polymorphisms, each represent a difference in a single 
nucleotide, and have been consistently proposed as participants in susceptibility towards 
diseases such as leprosy (Alvarado-Arnez et al., 2015:1; Economou et al., 2013; 
Donoghue et al., 2005; Monot et al., 2005). Monot et al. (2005) discovered four different 
SNP-types (1, 2, 3, and 4) and in 2009, divided these four types into sixteen SNP-
subtypes.  
The four main strains, or types, of Mycobacterium leprae are divided 
geographically. Monot et al. (2005) created a map (Figure 2 from Monot et al. 2005; 
Figure 14) showing the dissemination of the strains and their geographical pathways. 
According to their research, strain 1 occurs in East Africa, Asia, and the Pacific; strain 2 
in New Caledonia, Nepal/north India, Ethiopia, and Malawi; strain 3 in North Africa, 
Europe, and the Americas; and strain 4 in West Africa, Brazil, and the Caribbean islands 
(from Monot et al. Table 3, 2005:1041). 
Economou et al. (2013) found evidence of SNP-subtype 2G, a type that is found 
mainly in Asia/North Africa, in medieval Swedish remains (465). This finding is unique 
and remains one of the few tested samples from Europe that does not belong to SNP-type 
3, providing genetic evidence that a transmission of a particular type of the pathogen 
from Asia to Scandinavia had occurred during the medieval ages. Mendum et al. (2014) 
found evidence for SNP-type 2 strains in two skeletons from the medieval leprosarium of 
St Mary Magdalen near Winchester, England (2014). Monot et al. (2005) and Taylor and 
Donoghue (2011) have found evidence that SNP-type 3, a predominantly European and 
North American type, was present in some parts of Asia/Middle East in the Iron Age and 
medieval era. A 1st- 4th century CE adult skeleton from Uzbekistan was of subtype 3L 
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and four young adults from 4th century CE Dakhleh Oasis in Egypt had genotype 3. A 
large study by Donoghue et al. (2015), mostly on Hungarian samples, found SNP-
subtypes 3M and 3K, which was also found in a Turkish sample (253). Based on their 
results, the authors concluded that Avar (or Caucasus) migration from Central Asia into 
Byzantium and Central Europe exposed the disease to local populations.  
The exact route of transmission remains unclear, but there are two possible 
schemes for the spread of leprosy based on SNP types. The first, which Cole and Singh 
(2012) deem more probable, is that M. leprae evolved in East Africa and spread to 
Central Asia (SNP-type 2 preceding SNP-type 1, which migrated eastward, and SNP-
types 3 and 4 subsequently follow). The other scheme argues that M. leprae evolved in 
Central Asia and spread to East Africa following human migrations (SNP-type 1 
preceding SNP-type 2 and SNP-types 3 and 4 subsequently follow). The earliest accepted 
evidence (excluding the Bronze Age Scottish and Hungarian samples) of leprosy was 
found in a north Indian individual in 2009 and makes a strong argument for scheme two 
(Robbins et al., 2009). Thus, this study deems the second scheme the most likely 
scenario. 
Genotypes 1 and 4 remain mostly unique to their geographic regions – type 1 in 
Asia, the Pacific region, and East Africa and type 4 in West Africa and the Caribbean 
region, and South America (Monot et al., 2005; Cole and Singh, 2012). SNP-type 1 
originated in Asia, spread into East Africa, and then spread into the Pacific region 
through possible contact with, or immigration from, China or Japan (Trembly, 1995).  
SNP-type 4 was brought over into the Caribbean and South America through the 
18th century CE West African slave trade by infected European or North African 
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colonialists, explorers, traders, or West African slaves (Monot et al., 2005:1042). Much 
like how SNP-type 3 arrived in North America, infected Europeans with type-4 leprosy 
likely brought over the disease into the Caribbean and South America through early 
exploration, migration, and the slave trade. 
 
Figure 14. Dissemination of leprosy in the world [from Monot et al. (2005)]. The 
colored circles indicate the country of origin sampled and their division into the four 
SNP types. SNP-type 1 is yellow, SNP-type 2 is orange, SNP-type 3 is purple, and 
SNP-type 4 is green. The colored arrows represent migrations (Monot et al., 
2005:1042) 
Limitations in a Meta-Analysis 
Relying on data of human skeletons from bioarchaeological reports means relying 
on the authors’ quality of excavation and interpretation of skeletal pathologies. 
Additional limiting factors include burial preservation and excavation and post-
excavation treatment which makes the quality of the data highly variable (see Chapter 2; 
Roberts et al., 2003:13). Additionally, all articles that were not in English (the author’s 
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native language), Spanish or Hebrew, were translated through an online website. This 
could have resulted in possible translation issues or incorrect information.  
An apparent issue this project deals with is that several geographic areas and time 
periods have small samples sizes, or sometimes, none at all. One of the most obvious 
limitations in this study is its reliance on secondary sources. A possible bias lies in 
sample studies themselves as they are based on published studies available through the 
internet, the Boise State University library or its inter-library loan, or received from the 
authors themselves 
There is a known bias since 44 sites from 29 different references did not include 
total number of individuals excavated and were subsequently thrown out since the 
frequency of lesions (or percent of skeletons with leprosy) could not be calculated. In 
these excluded sites, 5 were from Sweden, 3 from Denmark, 25 from UK, 1 from Egypt, 
2 from Germany, 1 from Indonesia, 3 from Hungary, 2 from Israel, 1 from Poland, and 1 
from Ukraine. This data was entered into an excel sheet similarly to the data that was 
used in this study (supplementary text Appendix C). 
Bioarchaeological literature on leprosariums lead to a densely populated skeletal 
samples of people with leprosy in certain geographical areas, which may skew the results 
as skeletal samples without any leprosy lesions were not included. This suggests that the 
rate of leprosy may be lower than was calculated in this meta-analysis (given that skeletal 
samples with 0% leprosy prevalence were not included). Thus, the results of this meta-
analysis are supported by the author with the full understanding that its reliability 
depends on the validity of the studies (Walker et al., 2008:438).  
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Biocultural Applications 
This thesis’ conclusions are strained by the biocultural considerations discussed in 
Chapter 2. The problem of accurate estimation of leprosy’s impact continues to be an 
ongoing challenge for bioarchaeology and paleopathology. While this meta-analysis was 
successful in portraying leprosy’s frequency and lesion distribution in past populations 
based on the available paleopathological literature, the Osteological Paradox, political 
instability, and socioeconomic issues creates misrepresentation in accurate 
bioarchaeological assessments. Some countries are over-represented and others are 
grossly under-represented. It should also be remembered that, due to leprosy’s long 
incubation period which affects when bone changes develop, skeletons of children and 
those with a low resistant form of the disease are unlikely to show leprous lesions. The 
many intrinsic and extrinsic factors that affect whether or not someone shows signs of the 
infectious disease further complicates the picture. Clearly, it is unlikely that the frequency 
of leprosy was truly 8.76% of the total population. The skeletal material examined here 
only represents the individuals reported in the paleopathological literature and any 
assumptions on the demographic profile of the leprous individuals will be flawed. The 
data presented here tells us something about the impact of leprosy throughout time and 
space but the data is biased due to a number of different factors (Roberts, 2002b:216). 
More work is needed in order to obtain the real frequency of leprosy. Future careful 
excavation, recording, and analysis in additional geographic areas are needed to further 
interpretations on the impact and frequency of leprosy.  
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Conclusion and Further Directions 
Review 
Out of 18,787 total skeletal samples used in this data, the percentage of 
individuals that showed osteological signs of leprosy expressed in relation to total 
number of individuals was 8.756% (1,645 leprous skeletons). It is unlikely that leprosy 
was this prevalent in communities at any time, however.  Leprosy was at its peak in 
Northern Europe in the high medieval period (1200-1400 CE), slowly declining in the 
mid-13th century CE, and then dropping off dramatically by the end of the period (Covey, 
2001:320). This peak is correlated to the influx of leprosariums in that geographical 
region, especially in the UK and Denmark. Leprosy did not truly take effect in Europe 
until the late Iron Age, existing mostly in Asia and the Mediterranean until the sixth 
century.  
Further Directions 
The future of leprosy research is constantly marred by technological and 
methodological limitations. To keep up with curing leprosy today, research into leprosy’s 
impact in the past will need to continue, especially in non-European and post-medieval 
populations.  Additionally, continued methodological developments in lesion 
identification and prevalence is critical. As new paleopathological research continues to 
be published on leprosy, future meta-analyses will need to integrate this information with 
the new developing technique of aDNA analyses. 
Although there is no vaccine available for the prevention of leprosy, there are 
numerous prevention programs ran by the World Health Organization, the Centers for 
Disease Control and Prevention, the National Institute of Allergy and Infectious Diseases, 
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the United Nations Children’s Emergency Fund, LEPRA, the International Federation of 
Anti-Leprosy Associations, and the Movement of Reintegration of Persons Afflicted by 
Hansen’s disease. Ever since the World Health Organization provided MDT for free 
worldwide in 1995, leprosy rates keep decreasing every year (World Health 
Organization, 2016). However, leprosy is still a problem in dozens of countries with India 
accounting for over 60% of the total cases (as of 2012; WER 2012 Index). Despite these 
setbacks and continued prevalence of the disease, substantial progress has been made by 
providing free treatment to millions of affected individuals and in overcoming social 
stigma and exclusion. Hopefully, this progress will be further advanced through 
continued ongoing research into the basic understanding of the disease, the history and 
cause of its transmission, and improved treatments and vaccines. If it does, leprosy will 
one day no longer be one of the leading causes of physical disability and social stigma in 
the world as it was in the past (Bennet et al., 2008). 
67 
 
 
 
REFERENCES 
Alvarado-Arnez LE, Amaral EP, Sales-Marques C, Durães SMB, Sarno EN, Pacheco 
AG, Lana FCF, Moraes MO. 2015. Association of IL10 polymorphisms and 
leprosy: A meta-analysis. PLoS ONE 10:1-13. 
Anderson S. 1998. Leprosy in a medieval churchyard in Norwich. In: Anderson S, editor. 
Current and recent research in osteoarchaeology. Proceedings of the 3rd meeting 
of the Osteoarchaeology research group. Oxford: Oxbow Books. p 31-37. 
Antunes-Ferreira N, Matos VMJ, Santos AL. 2013. Leprosy in individuals unearthed near 
the Ermida de Santo Andre and leprosarium of Beja, Portugal. Anthropol Sci 
121:149-159. 
Arcini C. 1999. Health and disease in early Lund - osteopathologic studies of 3305 
individuals buried in the first cemetery area of Lund 990-1536. Archaeologica 
Lundensia VIII. Lund: Department of Community Health Sciences. 
Aufderheide AC, Rodríguez-Martín C. 1998. The Cambridge encyclopedia to human 
paleopathology. Cambridge: Cambridge University Press.  
Baker B, Bolhofner KL. 2014. Biological and social implications of a medieval burial 
from Cyprus for understanding leprosy in the past. Int J Paleopathol 4:17-24. 
Barber L, Sibun L. 1998. The medieval hospital of St Nicholas, Lewes, East Sussex: 
excavations 1994. Sussex archaeological collections ADS 148:1-42. 
Bax L, Yu L-M, Ikeda N, Moons KGM. 2007. A systematic comparison of software 
dedicated to meta-analysis of casual studies. BMC Med Res Methodol 7:40. 
Belcastro MG, Mariotti V, Facchini F, Dutour O. 2005. Leprosy in a skeleton from the 
7th century necropolis of Vicenne-Campochiaro (Molise, Italy). Int J 
Osteoarchaeol 15:431-448. 
68 
 
 
 
Bennett BH, Parker DL, Robson M. 2008. Leprosy: steps along the journey of 
eradication. Pub Health Rep 123:198-205. 
Bennike P, Lewis ME, Schutkowski H, Valentin F. 2005. Comparison of child morbidity 
in two contrasting medieval cemeteries from Denmark. Am J Phys Anthropol 
128:734-746. 
Blau S, Yagodin V. 2005. Osteoarchaeological evidence for leprosy from western Central 
Asia. Am J Phys Anthropol 126:150-158. 
Blondiaux J, Naji S, Bocquet-Appel J-P, Colard T, de Broucker A, de Seréville-Niel C. 
2015. The Leprosarium of Saint Thomas d'Aizier, the cementochronological proof 
of the medieval decline of Hansen disease in Europe? Int J Paleopathol. In press. 
Blondiaux J, Durr J, Khouchaf L, Eisenberg LE. 2002. Microscopic study and X-ray 
analysis of two 5th century cases of leprosy: palaeoepidemiological inferences. 
In: Roberts CA, Lewis ME, Manchester K, editors. The past and present of 
leprosy. Archaeological, historical, palaeopathological and clinical approaches. 
BAR International series 1054. Oxford: Archaeopress. p 105-110. 
Bloomfield M. 2004. Hymns of the Atharva Veda. Whitefish, MT: Kessinger Publishing. 
Boekhout TA. 2009. The puzzle of syphilis: a literature review on putting the pieces 
together. [thesis]. 
Boeckl CM. 2011. Images of leprosy: disease, religion, and politics in European art. 
Kirksville, MO: Truman State University Press. 
Boldsen JL, Rasmussen KL, Riis T, Dittmar M, Weise S. 2013. Schleswig: medieval 
leprosy on the boundary between Germany and Denmark. Anthropol Anz 70:273-
287. 
Boldsen JL. 2009. Leprosy in medieval Denmark - osteological and epidemiological 
analyses. Anthropol Anz 67:407-425. 
Boldsen JL. 2008. Leprosy in the early medieval Lauchheim community. Am J Phys 
Anthropol 135:301-310. 
69 
 
 
 
Boldsen JL, Mollerup L. 2006. Outside St. Jørgen: leprosy in the medieval Danish city of 
Odense. Am J Phys Anthropol 130:344-351. 
Boldsen JL, Freund UH. 2006. Osteological leprosy - epidemiology and diagnosis. Scan J 
Foren Sci 12:54-59. 
Boldsen JL. 2005a. Testing conditional independence in diagnostic palaeoepidemiology. 
Am J Phys Anthropol 128:586-592. 
Boldsen JL. 2005b. Leprosy and mortality in the medieval Danish village of Tirup. Am J 
Phys Anthropol 126:159-168. 
Boldsen JL. 2001. An epidemiological approach to the paleopathological diagnosis of 
leprosy. Am J Phys Anthropol 115:380-387. 
Boulter S. 1992. Death and disease in medieval Grantham. Unpublished Undergraduate 
Dissertation, University of Sheffield. 
Brander T, Lynnerup N. 2002. A possible leprosy hospital in Stubbekøbing, Denmark. In: 
Roberts CA, Lewis ME, Manchester K, editors. The past and present of leprosy. 
Archaeological, historical, palaeopathological and clinical approaches. BAR 
International series 1054. Oxford: Archaeopress. p 145-148. 
Bratschi MW, Steinmann P, Wickenden A, Gillis TP. 2015. Current knowledge on 
Mycobacterium leprae transmission: a systematic literature review. Lepr Rev 
86:142-155. 
Brothwell DR. 1958. Evidence of leprosy in British archaeological material. Med Hist 
2:287-291. 
Carvalho AS. 1932. História da lepra em Portugal. Oficinas Gráficas da Sociedade de 
Papelaria, Porto. 
Chen D-G, Peace KE. 2013. Applied meta-analysis with R. Boca Raton: CRC Press.  
Chundun Z, Roberts CA. 1995. Human skeletal remains, In: Cardwell P, editor. 
Excavation of the hospital of St Giles by Brompton Bridge, North Yorkshire. 
Archaeol J 152:214-220. 
70 
 
 
 
Cole ST, Singh P. 2012. History and phylogeography of leprosy. In: Nunzi E, Massone 
C, editors. Leprosy: a practical guide. London: Springer. 
Covey HC. 2001. People with leprosy (Hansen's disease) during the Middle Ages. Soc 
Sci J 38:315-321. 
Csóri ZS, Donoghue HD, Marcsik A. 2009. Leprosy in the 10th-13th century AD in 
Eastern Hungary. Ann Roum Anthropol 46:3-11. 
Daniel TM. 2006. The history of tuberculosis. Resp Med 100:1862-1870. 
Deeks JJ, Altman DG, Bradburn MJ. 2001. Statistical methods for examining 
heterogeneity and combining results from several studies in meta-analysis. In: 
Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: 
Meta-analysis in context, 2nd Edition. London: BMJ. 
Dewey M. 2015. CRAN task view: meta-analysis. CRAN R-Project. CRAN. 
<https://cran.r-project.org/web/views/MetaAnalysis.html>. 
Dharmendra R. 1947. Leprosy in ancient Indian medicine. Int J Lepr 15:424–430. 
Donoghue HD, Taylor GM, Marcsik A, Molnár E, Pálfi G, Pap I, Teschler-Nicola M, 
Pinhasi R, Erdal YS, Veleminsky P, Likovsky J, Belcastro MG, Mariotti V, Riga 
A, Rubini M, Zaio P, Besra GS, Lee OY-C, Wu HHT, Minnikin DE, Bull ID, 
O’Grady J, Spigelman M. 2015. A migration-driven model for the historical 
spread of leprosy in medieval Eastern and Central Europe. Infect Genet Evol 
31:250-256. 
Donoghue HD, Marcsik A, Matheson C, Vernon K, Nuorala E, Molto JE, Greenblatt CL, 
Spigelman M. 2005. Co-infection of Mycobacterium tuberculosis and 
Mycobacterium leprae in human archaeological samples: a possible explanation 
for the historical decline of leprosy. Proc Biol Sci 272:389-394. 
Duhig C. 1998. The human skeletal material In: The Anglo-Saxon cemetery at Edix Hill 
(Barrington A), Cambridgeshire. Council for British Archaeology Research 
Report. 
71 
 
 
 
Dzierzykray-Rogalski T. 1980. Paleopathology of the Ptolemaic inhabitants of Dakhleh 
Oasis (Egypt). J Hum Evol 9:71-74. 
Farley M, Manchester K. 1989. The cemetery of the leper hospital of St Margaret, High 
Wycombe, Buckinghamshire. Med Arch 33:82-89. 
Ferreira MT, Neves MJ, Wasterlain SN. 2013. Lagos leprosarium (Portugal): evidences 
of disease. J Archaeol Sci 40:2298-2307. 
Field A. 2013. Discovering statistics using IBM SPSS statistics. London: Sage 
Publications. p 1-952. 
Field A. 2012. Discovering statistics using R. 12th ed. London: Sage Publications. p 1-
957. 
Fornaciari G, Mallegni F, de Leo P. 1999. The leprosy of Henry VII: Incarceration or 
isolation? Lancet 353:758. 
Gamble JA. 2014. A bioarchaeological approach to stress and health in medieval 
Denmark: dental enamel defects and adult health in two medieval Danish 
populations. [dissertation]. 
Gausterer C, Stein C, Teschler-Nicola M. 2015. First genetic evidence of leprosy in early 
medieval Austria. Wien Med Wochenschr 165:126-132. 
Gilmore JK. 2008. Leprosy at the Lazaretto on St Eustatius, Netherlands Antilles. Int J 
Osteoarchaeol 18:72-84. 
Gladykowska-Rzeczycka JJ. 1976. A case of leprosy from a medieval burial ground. 
Folia Morphol Warsz 35:253–264. 
Glass GV. 1976. Primary, secondary, and meta-analysis of research. Educ Res 5:3-8. 
Granoff P. 1998. Cures and karma: healing and being healed in Jain religious literature. 
In: Baumgarten AI, Assmann J, Stroumsa G, editors. Self, soul, and body in 
religious experience. Leiden, Netherlands: Koninklijke Brill. 
Grmek MD. 1991. Diseases in the ancient Greek world. Baltimore: John Hopkins 
University Press.  
72 
 
 
 
Han XY, Seo Y-H, Sizer KC, Schoberle Y, May GS, Spencer JS, Li W, Nair RG. 2008. 
A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin 
Path 130:856-864. 
Holloway KL, Henneberg RJ, de Barros Lopes M, Henneberg M. 2011. Evolution of 
human tuberculosis: a systematic review and meta-analysis of paleopathological 
evidence. HOMO J Comp Hum Biol 62:402-458. 
Holst M. 2012. Osteological analysis. Dixon Lane and George Street York. York 
Osteoarchaeol Rep No 1612. 
Hulse EV. 1972. Leprosy and ancient Egypt. Lancet 300:1024-1025. 
Jensen KR, Tkocz I. 1983. Skeletmaterialet fra udgravningen af St. Jørgensgården i 
Odense. Dansk Med Historisk Arbog 1983. 
Johnson BT, Eagly AH. 2014. Meta-analysis of social-personality psychological 
research. In: Reis HT, Judd CM, editors. Handbook of research methods in social 
and personality psychology (2nd Ed.). Cambridge: Cambridge University Press. p 
675-707.  
Judd M, Roberts CA. 1998. Fracture patterns at the medieval leper hospital in Chichester. 
Am J Phys Anthropol 105:43-55. 
Khudaverdyan A. 2010. Pattern of disease in 2nd-1st millennium BC necropolis from 
Lchashen, Armenia. Anthropologie 158:239-254. 
Kjellström A. 2012. Possible cases of leprosy and tuberculosis in medieval Sigtuna, 
Sweden. Int J Osteoarchaeol 22:261-283. 
Köhler K, Marcsik A, Donoghue H, Márk L, Hajdu T. 2009. Előzetes eredmények az 
Abony 36. lelőhely késő rézkori áldozati gödreiből feltárt embertani leletek 
vizsgálata alapján. 
Kovalchik S. 2013. Tutorial on meta-analysis in R. R useR! Conference 2013.  
Kozak AD, Schultz M. 2006. Prokaza v drevnerusskom Kieve po dannym paleopatologii. 
Vestnik Antropologii 14:34–40. 
73 
 
 
 
Lancaster HO. 1990. Expectations of life: a study in the demography, statistics, and 
history of world mortality. New York: Springer-Verlag. p 1-611. 
Larsen CS. 2009. Emergence and evolution of agriculture: the impact on human health 
and lifestyle. In: Pond WG, Nichols BL, Brown DL, editors. Adequate food for 
all: culture, science and technology of food in the 21st century. Boca Raton, FL: 
CRC Press Taylor & Francis Group. 
Lechat MF. 2002. The palaeoepidemiology of leprosy: an overview. In: Roberts CA, 
Lewis ME, Manchester K, editors. The past and present of leprosy. 
Archaeological, historical, palaeopathological and clinical approaches. BAR 
International series 1054. Oxford: Archaeopress. p 157-162.  
Lee F, Magilton J. 1989. The cemetery of the hospital of St. James and St. Mary 
Magdalene, Chichester - A case study. World Archaeol 21:273-282. 
Lietman T, Porco T, Blower S. 1997. Leprosy and tuberculosis: the epidemiological 
consequences of cross- immunity. Am J Publ Health 87:1923-1927. 
Likovský J, Urbanová M, Hájek M, Cerny V, Cech P. 2006. Two cases of leprosy from 
Žatec (Bohemia), dated to the turn of the 12th century and confirmed by DNA 
analysis for Mycobacterium leprae. J Archaeol Sci 33:1276-1283. 
Linderholm A, Kjellström A. 2011. Stable isotope analysis of a medieval skeletal sample 
indicative of systemic disease from Sigtuna, Sweden. J Archaeol Sci 38:925-933. 
Lockwood DJ. 2002. Leprosy elimination – a virtual phenomenon or a reality? BMJ 
324:1516-1518. 
Lunt DA. 2013. The first evidence for leprosy in early mediaeval Scotland: two 
individuals from cemeteries in St. Andrews, Fife, Scotland, with evidence for 
normal burial treatment. Int J Osteoarchaeol 23:310-318. 
Lynnerup N, Boldsen J. 2012. Leprosy (Hansen’s disease). In: Grauer A, editor. A 
companion to paleopathology. Oxford: Wiley-Blackwell. p 458-471. 
Magilton J, Lee F, Boylston A. 2008. ‘Lepers outside the gate’. Excavations at the 
cemetery of the hospital of St James and St Mary Magdalene, Chichester, 1986-87 
74 
 
 
 
and 1993: Council for British archaeology research report 158 and Chichester 
excavations Volume 10, York. 
Manchester K, Roberts CA. 1986. Palaeopathological evidence of leprosy and 
tuberculosis in Britain. Unpublished SERC Report (Grant 337.367), University of 
Bradford. Unpublished. 
Marcsik A, Molnár, Osz B. 2007. Specifikus fertőző megbetegedések csontelváltozásai 
történeti népesség körében. JETE Press. 
Mariotti V, Dutour O, Belcastro MG, Facchini F, Brasili P. 2005. Probable early presence 
of leprosy in Europe in a Celtic skeleton of the 4th-3rd century BC (Casalecchio 
di Reno, Bologna, Italy). Int J Osteoarchaeol 15:311-325. 
Marks RB. 2015. The origins of the modern world: A global and environmental narrative 
from the fifteenth to the twenty-first century. 3rd edition, Lanham: Rowman & 
Littlefield. 
Matheson CD, Vernon KK, Lahti A, Fratpietro R, Spigelman M, Gibson S, Greenblatt 
CL, Donoghue HD. 2009. Molecular exploration of the first-century Tomb of the 
Shroud in Akeldama, Jerusalem. PLoS ONE 4:e8319. 
Mays S. 1991. The medieval burials from the Blackfriars Friary, School Street, Ipswich, 
Suffolk (Excavated 1983-1985). Ancient Monuments Laboratory Report 16/91. 
English Heritage: Portsmouth. 
Mays S. 1989. The Anglo-Saxon human bone from School Street, Ipswich, Suffolk. 
Ancient Monuments Laboratory Report 115/89, English Heritage. Unpublished. 
Mendum TA, Schuenemann VJ, Roffey S, Taylor GM, Wu H, Singh P, Tucker K, Hinds 
J, Cole ST, Kierzek AM, Nieselt K, Krause J, Stewart GR. 2014. Mycobacterium 
leprae genomes from a British medieval leprosy hospital towards understanding 
an ancient epidemic. BMC Genomics 15:270. 
Mészáros P, Paluch T, Sóskuti K, Sz Wilhelm G. 2006 Felgyő, Kettőshalmi-dűlő. In: 
Régészeti Kutatások Magyarországon, 2005- Archaeological investigations in 
Hungary, 2005, Budapest, 199-200. 
75 
 
 
 
Meyer C, Jung C, Kohl T, Poenicke A, Poppe A, Alt KW. 2002. Syphilis 2001: a 
palaeopathological reappraisal. HOMO J Comp Hum Biol 53:39-58. 
Miller TS, Nesbitt JW. 2014. Walking corpses: leprosy in Byzantium and the medieval 
west. Ithaca: Cornell University Press. 
Møller-Christensen V. 1978. Leprosy changes of the skull. Odense: Odense University 
Press. 
Møller-Christensen V. 1967. Evidence of leprosy in earlier peoples. In: Brothwell DR, 
Sandison AT, editors. Diseases in antiquity. Springfield, IL: Charles Thomas. p 
295– 306. 
Møller-Christensen, V. 1965. New knowledge of leprosy through paleopathology. Int J 
Lepr Other Mycobact Dis 33:603-610. 
Møller-Christensen V, Faber B. 1952. Leprous changes in a material of medieval 
skeletons from the St. Georges Court, Næstved. Acta Radiol [Old Series] 37:308– 
317. 
Molnár E, Donoghue HD, Lee OY-C, Wu HHT, Besra GS, Minnikin DE, Bull ID, 
Llewellyn G, Williams CM, Spekker O, Pálfi G. 2015. Morphological and 
biomolecular evidence for tuberculosis in 8th century AD skeletons from 
Belmegyer-Csomoki Domb, Hungary. Tuberculosis 95:S35-S41. 
Molnár E, Marscik A. 2002. Paleopathological evaluation of Hungarian skeletal remains 
from the 7th-9th centuries AD. Antropol Portuguesa 19:85-99. 
Molto JE. 2002. Leprosy in Roman period skeletons from Kellis 2, Dakhleh, Egypt. In: 
Roberts CA, Lewis ME, Manchester K, editors. The past and present of leprosy. 
Archaeological, historical, palaeopathological and clinical approaches. BAR 
International series 1054. Oxford: Archaeopress. p 179-192. 
Monot M, Honoré N, Garnier T, Zidane N, Sheradi S, Paniz-Mondolfi A, Matsuoka M, 
Taylor GM, Donoghue HD, Bouwman A, Mays S, Watson C, Lockwood D, 
Khamispour A, Dowlati Y, Jianping S, Rea TH, Vera-Cabrera L, Stefani MM, 
Banu S, Macdonald M, Sapkota BR, Spencer JS, Thomas J, Harshman K, Singh 
P, Busso P, Gattiker A, Rougemont J, Brennan PJ, Cole ST. 2009. Comparative 
76 
 
 
 
genomic and phylogeographic analysis of Mycobacterium leprae. Nat Gen 
41:1282-1289. 
Monot M, Honoré N, Garnier T, Araoz R, Coppée J-Y, Lacroix C, Sow S, Spencer JS, 
Truman RW, Williams DL, Gelber R, Virmond M, Flageul B, Cho S-N, Ji B, 
Paniz-Mondolfi A, Convit J, Young S, Fine PE, Rasolofo V, Brennan PJ, Cole 
ST. 2005. On the origin of leprosy. Science 308:1040-1042. 
Montiel R, García C, Cañadas MP, Isidro A, Guijo JM, Malgosa A. 2003. DNA 
sequences of Mycobacterium leprae recovered from ancient bones. FEMS 
Microbiol Lett 226:413-414. 
Murphy E, Manchester K. 2002. Evidence for leprosy in medieval Ireland. In: Roberts 
CA, Lewis ME, Manchester K, editors. The past and present of leprosy. 
Archaeological, historical, palaeopathological and clinical approaches. BAR 
International series 1054. Oxford: Archaeopress. p 193-199. 
Neil B. 2003. 2003 Anglo-Georgian Nokalakevi expedition: Osteological assessment for 
trench A and B. p 1-21. 
Nerlich AG, Zink AR. 2008. Past leprae. In: Raoult D, Drancourt M, editors. 
Paleomicrobiology: past human infections.  
Nuorala E, Donoghue HD, Spigelman M, Götherström A, Hårding B, Grundberg L, 
Alexandersen V, Leden I, Lidén K. 2004. Diet and disease in Björned, a Viking-
early medieval site in northern Sweden. Theses and Papers in Scientific 
Archaeology. Stockholm: Archaeological Research Laboratory. 
Pálfi G, Molnár E. 2009. The paleopathology of specific infectious diseases from 
Southeastern Hungary: A brief overview. Acta Biol Szeged 53:111-116. 
Pálfi G, Zink A, Haas CJ, Marcsik A, Dutour O, Nerlich AG. 2002. Historical and 
palaeopathological evidence of leprosy in Hungary. In: Roberts CA, Lewis ME, 
Manchester K, editors. The past and present of leprosy. Archaeological, historical, 
palaeopathological and clinical approaches. BAR International series 1054. 
Oxford: Archaeopress. p 205-212. 
77 
 
 
 
Pálfi G. 1997. Maladies dans l'antiquité et au Moyen-Âge. Paléopathologie comparée des 
anciens Gallo-Romains et Hongrois. Bulletins et Mémoires de la Société 
d’Anthropologie de Paris. Nouvelle série 9:1–206. 
Pálfi G. 1991. The first osteoarchaeological evidence of leprosy in Hungary. Int J 
Osteoarchaeol 1:99-192. 
Pardillo FEF, Fajardo TT, Abalos RM, Scollard D, Gelber RH. 2007. Methods for the 
classification of leprosy for treatment purposes. Clin Infect Dis 44:1096-1099. 
Pearson K. 1904. Mathematical contributions to the theory of evolution. Philosophical 
transactions of the royal society of London. Series A, containing papers of a 
mathematical or physical character 195:1-47,405. 
Pearson K. 1900. On the criterion that a given system of deviations from the probable in 
the case of a correlated system of variables is such that it can be reasonably 
supposed to have arisen from random sampling. Philosophical Magazine Series 
50:157-175. 
Polet C. 2011. Health and diet of ancient Easter Islanders: Contribution of 
paleopathology, dental microwear, and stable isotopes. Royal Belgian Institute of 
Natural Sciences. p 1-19. 
Porter D. 1999. Health, civilization, and the state: a history of public health from ancient 
to modern times. London and New York: Routledge. 
Powell F. 1996. The human remains. In: Raunds Furnells. The Anglo-Saxon church and 
churchyard. English Heritage Archaeological Report. 
Primeau C, Linnerup N. 2014. Non-bony lesions and functional losses in leprosy 
[abstract]. Am J Phys Anthropol Suppl. p 16. 
Rasmussen KL, Boldsen JL, Kristensen HK, Skytte L, Hansen KL, Mølholm L, Grootes 
PM, Nadeau M-J, Eriksen KMF. 2008. Mercury levels in Danish Medieval human 
bones. J Archaeol Sci 35:2295-2306. 
Reader R. 1974. New evidence for the antiquity of leprosy in early Britain. J Archaeol 
Sci 1:205-207. 
78 
 
 
 
Robbins G, Tripthy VM, Misra VN, Mohanty RK, Shinde VS. 2009. Ancient skeletal 
evidence for leprosy in India (2000 B.C.). PLoS ONE 4:e5669. 
Roberts CA. 2011. Chapter 9: The bioarchaeology of leprosy and tuberculosis. In: 
Agarwal SC, Glencross BA, editors. Social bioarchaeology. Oxford: Wiley-
Blackwell. p 252-282. 
Roberts CA, Cox M. 2007. The impact of economic intensification and social complexity 
on human health in Britain from 4000 BC (Neolithic) and the introduction of 
farming to the mid-19th century AD and industrialization (post-Medieval period). 
In: Cohen MN, Crane-Kramer GMM, editors. Ancient health: skeletal indicators 
of agricultural and economic intensification. Gainesville: University Press of 
Florida. p. 149-63. 
Roberts CA, Cox M. 2003. Health and disease in Britain. From prehistory to the present 
day. Gloucester: Sutton. 
Roberts CA, Lewis ME, Manchester K. 2002. The past and present of leprosy. 
Archaeological, historical, palaeopathological and clinical approaches. BAR 
International series 1054. Oxford: Archaeopress.  
Roberts CA. 2002a. Palaeopathology and archaeology: the current state of play. In: The 
archaeology of medicine. BAR International series 1046. Oxford: Archaeopress. p 
1-20. 
Roberts CA. 2002b. The antiquity of leprosy in Britain: the skeletal evidence. In: Roberts 
CA, Lewis ME, Manchester K, editors. The past and present of leprosy. 
Archaeological, historical, palaeopathological and clinical approaches. BAR 
International series 1054. Oxford: Archaeopress. p 213-222. 
Roberts CA, Manchester K. 1995. The archaeology of disease. Ithaca, NY: Cornell 
University Press. 
Roberts J. 2007. Human remains from the cists. In: Dunwell A, editors. Cist burials and 
an Iron Age settlement at Dryburn Bridge, Innerwick, East Lothian. Scottish 
Archaeological Internet Report 24:18-25. 
79 
 
 
 
Roffey S. 2012. Medieval leper hospitals in England: An archaeological perspective. 
Mediev Archaeol 56:203-233. 
Rothstein HR, Hopewell S. 2009. Chapter 6: Grey literature. In: Cooper H, Hedges LV, 
Valentine JC, editors. The handbook of research synthesis and meta-analysis. 
New York: Russell Sage Foundation. p 103-128. 
Rubini M, Zaio P, Roberts CA. 2014. Tuberculosis and leprosy in Italy-new skeletal 
evidence. HOMO J Comp Hum Biol 65:13-32. 
Rubini M, Dell’Anno V, Giuliani R, Favia P, Zaio P. 2012. The first probable case of 
leprosy in Southeast Italy (13th-14th centuries AD, Montecorvino, Puglia). J 
Anthropol. p 1-7. 
Rubini M, Erdal YS, Spigelman M, Zaio P, Donoghue HD. 2012. Paleopatholoical and 
molecular study on two cases of ancient childhood leprosy from the Roman and 
Byzantine empires. Int J Osteoarchaeol 24:570-582. 
Rubini M, Zaio P. 2009. Lepromatous leprosy in an early mediaeval cemetery in central 
Italy (Morrione, Campochiaro, Molise, 6th-8th century AD). J Archaeol Sci 
36:2771-2779. 
Schmitz-Cliever E. 1972. Das mittelalterliche leprosarium Mela- tan bei Aachen. Clio 
Medica 7:13–34. 
Schuenemann VJ, Singh P, Mendum TA, Krause-Kyora B, Jäger G, Bos KI, Herbig A, 
Economou C, Benjak A, Busso P, Nebel A, Boldsen JL, Kjellström A, Wu H, 
Stewart GR, Taylor GM, Bauer P, Lee OY-C, Wu HHT, Minnikin DE, Bersa GS, 
Tucker K, Roffey S, Sow SO, Cole ST, Nieselt K, Krause J. 2013. Genome-wide 
comparison of medieval and modern Mycobacterium leprae. Science 341:179-
184. 
Setia MS, Steinmaus C, Ho CS, Rutherford GW. 2006. The role of BCG in prevention of 
leprosy: a meta-analysis. Lancet Infect Dis 6:162-170. 
Setzer TJ. 2014. Malaria detection in the field of paleopathology: A meta-analysis of the 
state of the art. Acta Trop 140:97-104. 
80 
 
 
 
Simpson SJY. 1872. On leprosy and leper hospitals in Scotland and England. In: Stuart J, 
editor. Archaeological Essays 2:1-184. 
Smith SE. 2010. Human and mycobacterial coevolution: The role of genetic 
recombination in reconstructing the evolutionary history of these important 
human pathogens. [dissertation]. 
Smith-Guzmán NE. 2015. Cribra orbitalia in the ancient Nile Valley and its connection to 
malaria. Int J Paleopathol 10:1-12. 
Stone AC, Wilbur AK, Buikstra JE, Roberts CA. 2009. Tuberculosis and leprosy in 
perspective. Yearb Phys Anthropol 52:66-94. 
Stones JA, editor. 1989. Three Scottish carmelite friaries: excavations at Aberdeen, 
Linlithgow and Perth 1980-1986. Society of Antiquaries of Scotland. 
Strouhal E, Ladislava H, Likovsky J, Vargova L, Danes J. 2002. Traces of leprosy from 
the Czech Kingdom. In: Roberts CA, Lewis ME, Manchester K, editors. The past 
and present of leprosy. Archaeological, historical, palaeopathological and clinical 
approaches. BAR International series 1054. Oxford: Archaeopress. p 223-232. 
Suzuki K, Saso S, Hoshino K, Sakurai J, Tanigawa K, Luo Y, Ishido Y, Mori S, Hirata K, 
Ishii N. 2014. Paleopathological evidence and detection of Mycobacterium leprae 
DNA from archaeological skeletal remains of Nabe-kaburi (head-covered with 
iron pots) burials in Japan. PLoS ONE 9:1-9. 
Suzuki K, Takigawa W, Tanigawa K, Nakamura K, Ishido Y, Kawashima A, Wu H, 
Akama T, Sue M, Yoshihara A, Mori S, Ishii N. 2010. Detection of 
Mycobacterium leprae DNA from archaeological remains in Japan using whole 
genome amplification and polymerase chain reaction. PLoS ONE 5:1-8. 
Szilvássy J. 1980 Die Skelette aus dem awarischen Gräberfeld von Zwölfaxing in 
Niederösterreich. Anthropologische Forschungen 3, Wein, Austria. 
Tayles N, Buckley HR. 2004. Leprosy and tuberculosis in Iron Age Southeast Asia? Am 
J Phys Anthropol 125:239-256. 
81 
 
 
 
Taylor GM, Donoghue HD. 2011. Multiple loci variable Number tandem repeat (VNTR) 
analysis (MLVA) of Mycobacterium leprae isolates amplified from European 
archaeological human remains with Lepromatous leprosy. Microbes Infect 
13:923-929. 
Taylor GM, Watson CL, Bouwman AS, Lockwood DNJ, Mays SA. 2006. Variable 
nucleotide tandem repeat (VNTR) typing of two palaeopathological cases of 
lepromatous leprosy from mediaeval England. J Archaeol Sci 33:1569-1579. 
Trembly DL. 1995. On the antiquity of leprosy in Western Micronesia. Int J 
Osteoarchaeol 7:621-624. 
Truman R. 2005. Leprosy in wild armadillos. Lepr Rev 76:198-208. 
Vuorinen HS. 2002. History of leprosy in Finland. In: Roberts CA, Lewis ME, 
Manchester K, editors. The past and present of leprosy. Archaeological, historical, 
palaeopathological and clinical approaches. Oxford: Archaeo Press. p 239–246. 
Walker D. 2009. The treatment of leprosy in 19th century London: a case study from St 
Marylebone cemetery. Int J Osteoarchaeol 19:364-374. 
Walker E, Hernandez AV, Kattan MW. 2008. Meta-analysis: Its strengths and 
limitations. Cleve Clin J Med 75:431-439. 
Watson CL, Lockwood DNJ. 2009. Single nucleotide polymorphism analysis of 
European archaeological M. leprae DNA. PLoS ONE 4:e7547. 
Weiss D, Møller-Christensen V. 1971. Leprosy, echinococcosis and amulets: a study of a 
medieval Danish inhumation. Med Hist 15:260-267. 
Wells C. 1967. A leper cemetery at South Acre, Norfolk. Mediev Archaeol 11:242-248. 
Wiggins R, Boylston A, Roberts CA. 1993. Report on human skeletal remains from 
Blackfriars, Gloucester (19/91). Unpublished. 
Wood JW, Milner GR, Harpending HC, Weis KM. 1992. The osteological paradox. Curr 
Anthropol 33:343-370. 
82 
 
 
 
World Health Organization (WHO). 2016. Leprosy elimination: WHO multidrug therapy 
(MDT). Geneva: The World Health Organization. 
<http://www.who.int/lep/mdt/en/>.  
World Health Organization in the Western Pacific Region (WPRO). 2016. Eliminating 
leprosy in the Western Pacific. WHO Western Pacific regional office. 
<http://www.wpro.who.int/leprosy/elimination/en/>. 
World Health Organization (WHO). 2012. Global leprosy situation. Weekly 
epidemiological record (WER) 87:317-328. 
Yammine K. 2014. The prevalence of os acromiale: A systematic review and meta-
analysis. Clin Anat 27:610-621. 
Zhang Z. 1994. The skeletal evidence of human leprosy and syphilis in ancient China. 
Acta Anthropol Sin 13:294–299. 
Zias J. 2002. New evidence for the history of leprosy in the Ancient Near East: an 
overview. In: Roberts CA, Lewis ME, Manchester K, editors. The past and 
present of leprosy. Archaeological, historical, palaeopathological and clinical 
approaches. BAR International series 1054. Oxford: Archaeopress. p 259-268. 
Zodpey SP. 2007. Protective effect of bacillus Calmette Guerin (BCG) vaccine in the 
prevention of leprosy: A meta-analysis. Indian J Dermatol Venereol Leprol 73:86-
93. 
Zweifel L, Böni T, Rühli FJ. 2009. Evidence-based palaeopathology: Meta-analysis of 
PubMed-listed scientific studies of ancient Egyptian mummies. HOMO J Comp 
Hum Biol 60:405-427. 
83 
 
 
 
APPENDIX A 
References Included in Data 
 
84 
 
 
 
 
85 
 
 
 
 
86 
 
 
 
 
87 
 
 
 
 
 
88 
 
 
 
APPENDIX B 
All References Searched 
[See supplementary content in ScholarWorks.] 
89 
 
 
 
APPENDIX C 
References Excluded from Data 
[See supplementary content in ScholarWorks] 
